ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID
NODE_2_length_647550_cov_15.6193_614 # 645337 # 645570 # 1 # ID=2_614;partial=00;start_type=ATG;rbs_motif=4Base/6BMM;rbs_spacer=13-15bp;gc_cont=0.368	NODE_2_length_647550_cov_15.6193_614 	645337	645570	+	Loose	500	23.483	APH(3')-Ib	35.0	3002642	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	ATGAATGATAAAAACACATACTCTGTTGATAAATATTTGGAAATCATTGCCGAAAAAGAAGGAATCACAAAAGAAGAAGTCCAACAGGAAATTGGGCGGGCAGTTTCCATTGCTTTAAAAAGCCCTGATCCAAAAATGCAACGCTTCTGGACAGACTTTCCATGTGAAAATGATACTCCCACCATTGAAGAAATCATATACCATCTCGCTGAAAAATTTGCAAAAGAGTCATAG	MNDKNTYSVDKYLEIIAEKEGITKEEVQQEIGRAVSIALKSPDPKMQRFWTDFPCENDTPTIEEIIYHLAEKFAKES	MNDIDREEPCAAAAVPESMAAHVMGYKWARDKVGQSGCAVYRLHSKSGGSDLFLKHGKDAFADDVTDEMVRLRWLAGHISVPSVVSFVRTPNQAWLLTTAIHGKTAYQVLKSDFGARLVVVDALAAFMRRLHAIPVSECSVQQWTTHAGLPERGSIEAGVVDVDDFDKEREGWTAEQVWEAMHRLLPLAPDPVVTHGDFSLDNLLIVEGKVVGCIDVGRAGIADRYQDLAVLWNCLEEFEPSLQERLVAQYGIADPDRRKLQFHLLLDELF	28.41	gnl|BL_ORD_ID|806|hsp_num:0	835
NODE_5_length_337725_cov_18.5772_26 # 27353 # 27538 # -1 # ID=5_26;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.344	NODE_5_length_337725_cov_18.5772_26 	27353	27538	-	Loose	500	22.3274	PER-3	40.74	3002365	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; penam; penem	antibiotic inactivation	PER beta-lactamase	ATGAGGCATTTAAGGCAATTCAGTAGAAAATTCAGTAAAAACGTCATTTGTGATAAATCCTTCATTTTACAGGAGACCCCATGGAGAATCAGCATGGGGTCTCTTTTTATGCAAAATGTTCTCATTTTAGAACACGTAAATGCATTGAATTTCGTGAATAACGAGTATACAATTAGTGGTAGCTAA	MRHLRQFSRKFSKNVICDKSFILQETPWRISMGSLFMQNVLILEHVNALNFVNNEYTISGS	MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLLINPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDEFSVPVQQLLQYSVSLSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQVQYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKTGTSGIKAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQTAYQFELKKLSALSPN	19.81	gnl|BL_ORD_ID|1514|hsp_num:0	1589
NODE_41_length_143579_cov_18.8119_5 # 2683 # 4602 # -1 # ID=41_5;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.411	NODE_41_length_143579_cov_18.8119_5	2683	4602	-	Strict	1200	1201.42	tet32	89.97	3000196	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAAAATAATCAATATTGGAATTCTCGCCCATGTAGACGCAGGAAAAACAACATTGACGGAAAGCCTGCTGTACACCAGTGGAGCGATTGCGGAACAAGGAAACGTGGATAAAGGAACTACAAGAACAGACACTATGATTTTGGAACGGCAGCGCGGAATTACCATTCAGACAGCGGTTACTTCTTTTTGCTGGAATGATTATAAAATCAATATCGTGGACACTCCCGGTCATATGGATTTTTTAACCGAAGCATACCGCTCTTTATCTGTCCTTGACGGAGCTGTTTTAGTCATTTCGGCAAAAGACGGCGTACAGGCACAAACCCGTATATTATTCCATGCGCTTCAGAAAATGGACATTCCGACAATTATCTTTATAAATAAGATAGACCAAAATGGGATCGACCTGCGGCGTGTTTACCAAAGCATTAAAGATAAACTTACCAGTGATATGATTGTCATGCAGGAGGTTTCCCTGTCGCCAAAGATAACCATGACCGATATTTCTGATTTGGACAAATGGGATATGATTATTTCCGGAAGCGATGAACTATTAGAACGATATGTTGCAGAGGATTCTTTGGATATACAGGAATTACAATATGAAAAGTGCAAAAGAACCAGATGCTGCTCTTTGTTTCCTGTTTATCATGGGAGTGCAAAAGACAATTTAGGAACAGAAAAACTGATTGAAGCGATTACAGAAACTTTCATTACAGAAACAGACGATATTCAGTCTGAATTATGTGGATATGTTTTTAAGGTTGAGTATACAGAGCGGAAAAAACGGCTTTCTTATTTACGCCTGTATCATGGGACGCTCCATTTACGGGATACCCTGCTGCTGTCAAAAAAGGAAAAAATAAAGATTACAGAAATGTGTATTCCGTCAAATGGTGAAATCGTCCCGGTTGACCATGCCTGTCCGGGAGAAATTGTTATTTTAGCTGATGATACTTTGAAACTGAACGACATTCTGGGAAATGAAAAACTCCTGCCTCACAAAACACGGATTGATAATCCCATGCCATTACTTCGGACAACGGTAGAGCCGCAAAAGCCGGAGCAAAGGGAAGCCCTGTTAAATGCCCTCACAGAGATTGCTGATACAGACCCTCTTTTGCATTTTGACATTGATACTGTTACACATGAGATTATATTATCTTTTTTGGGAAAAGTACAGTTAGAAGTTATTTGTTCGCTATTAGAAGAAAAATATCATGTGGGCGTGGCTATGAAAGAGCCTTCGGTTATTTATCTGGAAAGACCGCAAAAAAAAGCGAGCTACACGATTCATATTGAAGTGCCGCCGAATCCGTTTTGGGCATCTATTGGTTTGACTGTAACACCGCTTCCTGTTGGAAGCGGAACACAATATAAAAGCGAGGTATCTCTCGGCTATTTAAACCAAAGTTTTCAAAATGCCGTCATGGAGGGTGTGCGTTATGGAATGGAGCAGGGCTTATATGGCTGGGGAGTGACAGACTGCCAAATTTGTTTTGATTATGGAGTTTATTACAGCCCGGTCAGCACCCCCGCTGATTTTCGTTTTCTTGCGCCTGTCGTGTTGGAGCAGGCATTGAAAAAAGCAGGAACACAACTGTTGGAACCATACCTTTCCTTTACCCTTTTTGCACCGCAGGAATATCTTTCACGGGCTTATAATGACGCACCAAAGTATTGCGCAATCATTGAATCAACCAGACTTGAAAAAGATGAAGTTATTTTTAAGGGGGAAATCCCTGCCCGTTGTATTGGTGAATATAGAAATGATTTGAATTTTTATACAAATGGAAGAAGTGTCTGCATTACAGAATTAAAAGGGTATCAGGAAACTTCCGGCGAGCCTGTGTTTCAGCCACGCCGCCCGAACAGCCGTTTAGACAAGATCCGGCATATGTTTCAGAAGATAATGTAA	MKIINIGILAHVDAGKTTLTESLLYTSGAIAEQGNVDKGTTRTDTMILERQRGITIQTAVTSFCWNDYKINIVDTPGHMDFLTEAYRSLSVLDGAVLVISAKDGVQAQTRILFHALQKMDIPTIIFINKIDQNGIDLRRVYQSIKDKLTSDMIVMQEVSLSPKITMTDISDLDKWDMIISGSDELLERYVAEDSLDIQELQYEKCKRTRCCSLFPVYHGSAKDNLGTEKLIEAITETFITETDDIQSELCGYVFKVEYTERKKRLSYLRLYHGTLHLRDTLLLSKKEKIKITEMCIPSNGEIVPVDHACPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREALLNALTEIADTDPLLHFDIDTVTHEIILSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIYLERPQKKASYTIHIEVPPNPFWASIGLTVTPLPVGSGTQYKSEVSLGYLNQSFQNAVMEGVRYGMEQGLYGWGVTDCQICFDYGVYYSPVSTPADFRFLAPVVLEQALKKAGTQLLEPYLSFTLFAPQEYLSRAYNDAPKYCAIIESTRLEKDEVIFKGEIPARCIGEYRNDLNFYTNGRSVCITELKGYQETSGEPVFQPRRPNSRLDKIRHMFQKIM	MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAVTSFQWEDVKVNIIDTPGHMDFLTEAYRSLSVLDGAVLVISAKDGVQAQTRILFHALQKMNIPTIIFINKIDQNGIDLQRVYQSIKDKLTSDMIVMQEVSLSPKITMTDISDLDKWDMIISGSDELLERYVAEDSLDIQELQYEKCKRTRCCSLFPVYHGSAKDNLGTEKLIEAITETFITETDDIQSELCGYVFKVEYTERKKRLSYLRLYHGTLHLRDTLLLSKKEKIKITEMCIPSNGEIVPVDHACPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREALLNALTEIADTDPLLHFDIDTVTHEIILSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIYLERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEGVLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYLHFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQGVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA	100.00	gnl|BL_ORD_ID|1179|hsp_num:0	1233
NODE_99_length_94913_cov_13.5691_42 # 50238 # 51233 # -1 # ID=99_42;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.619	NODE_99_length_94913_cov_13.5691_42 	50238	51233	-	Loose	275	25.409	AAC(6')-Ie-APH(2'')-Ia	26.92	3002597	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(2''); AAC(6')	ATGTTTGATTTTGTGTCCTTTATCCCCCGCGCCATCGTACAGGGTATCCCGCTGCTGTTCGGCAGCACCGGCGAAACGCTCACCGAAAAGTCCGGCAACCTGAACCTCGGCATCGCGGGCATCATGTATGTCGGCGGCATCAGCGGCGTCATCGGTGCGTTCCTGTATGAGCAGGCGGCCGGCGGAGCCGCCGGGATGAACGGCTTTCTCGCCATCATGATCCCGCTGCTGTCGTGCCTGCTCGGCTCGCTGCTCATGGGACTGCTGTACTGCTTTCTCACCGTCACGCTGCGCGCCAACCAGAACGTCACCGGCCTTGCCATGACGACGTTCGGCGTCGGCTTCGGCAACTTCATGGGCGGCTCGCTCATCAAGCTCACCGGCAGCGAGGTGCCGTCCATCGCGCTCTCGGCCACGAACAGCTACTTTTCCAAGTCGCTGCCGCTTGCCGATAAGCTCGGCTGGTTCGGCCAGATCTTCCTGTCCTACGGCTTTCTCGCTTACCTCGCCGTGGCCATCGCGCTCATCGCGGCCTACGTGCTCAAGCACACGCGCGTGGGTCTGCACCTGCGCTCCGTCGGCGAAAATCCGCAGACGGCCGACGCCGCCGGCATCGACGTCAAGAAATATAAGTATGTCGCCACCTGCGTCGGCAGCATGATCGCCGGCCTCGGCGGATTGTACTACGTCATGGACTACGCCTGCGGTGTCTGGTCCAACGACGCCTTCGGCGACCGCGGCTGGCTCGCCATTGCGCTCGTCATCTTCACGGTTTGGAAGCCAAACATCGGCGTGCTCGCGTCGTTCCTCTTCGGCGGCCTGTACATCCTGCACATCTTCCTGCCGAGCGGCACGAACCTCGCCGTCAAGGAACTGTACAAGATGATCCCCTATGTCGTCACGATCATCGTGCTCATCATCACGAGCGTGCGCTCCAAGCGCGAAAATCAGCCCCCCGCAAGCCTCGGCCTGCCGTATTTCCGAGAAGAACGGTAA	MFDFVSFIPRAIVQGIPLLFGSTGETLTEKSGNLNLGIAGIMYVGGISGVIGAFLYEQAAGGAAGMNGFLAIMIPLLSCLLGSLLMGLLYCFLTVTLRANQNVTGLAMTTFGVGFGNFMGGSLIKLTGSEVPSIALSATNSYFSKSLPLADKLGWFGQIFLSYGFLAYLAVAIALIAAYVLKHTRVGLHLRSVGENPQTADAAGIDVKKYKYVATCVGSMIAGLGGLYYVMDYACGVWSNDAFGDRGWLAIALVIFTVWKPNIGVLASFLFGGLYILHIFLPSGTNLAVKELYKMIPYVVTIIVLIITSVRSKRENQPPASLGLPYFREER	MNIVENEICIRTLIDDDFPLMLKWLTDERVLEFYGGRDKKYTLESLKKHYTEPWEDEVFRVIIEYNNVPIGYGQIYKMYDELYTDYHYPKTDEIVYGMDQFIGEPNYWSKGIGTRYIKLIFEFLKKERNANAVILDPHKNNPRAIRAYQKSGFRIIEDLPEHELHEGKKEDCYLMEYRYDDNATNVKAMKYLIEHYFDNFKVDSIEIIGSGYDSVAYLVNNEYIFKTKFSTNKKKGYAKEKAIYNFLNTNLETNVKIPNIEYSYISDELSILGYKEIKGTFLTPEIYSTMSEEEQNLLKRDIASFLRQMHGLDYTDISECTIDNKQNVLEEYILLRETIYNDLTDIEKDYIESFMERLNATTVFEGKKCLCHNDFSCNHLLLDGNNRLTGIIDFGDSGIIDEYCDFIYLLEDSEEEIGTNFGEDILRMYGNIDIEKAKEYQDIVEEYYPIETIVYGIKNIKQEFIENGRKEIYKRTYKD	69.10	gnl|BL_ORD_ID|1737|hsp_num:0	1814
NODE_119_length_88247_cov_12.0439_88 # 88055 # 88243 # 1 # ID=119_88;partial=00;start_type=ATG;rbs_motif=TAAAAA;rbs_spacer=12bp;gc_cont=0.376	NODE_119_length_88247_cov_12.0439_88 	88055	88243	+	Loose	500	23.483	vanWG	50.0	3002965	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanW; glycopeptide resistance gene cluster	ATGGCACTAAAACAGTATTTCTATATCGTTTTAGTGCCATTGAAGTTTATACCAAAACGAACCGCTTCGTTTTGGCAAACTATAAAAATACCGAACCGCTTCGTTTTGAAAATTTGTACGGGTGGTTTTGCGGATTATACACGCAACATTCTCTCGTTCAGTTTTTCCTGCATCCTGTCAATGAAATAG	MALKQYFYIVLVPLKFIPKRTASFWQTIKIPNRFVLKICTGGFADYTRNILSFSFSCILSMK	MIEVYKLTQRKRLTQLFPFLLPLRKWQRKKYFYFKMKFDGNRYAKKTSEKLLPNTVFETSSLMLNENSGFDMKYQINKVHNLKLAAKTINKVIIEPKETFSFWQLVRWADRHEKYKDGLNLVNGKIVGSYGGGLCQLSNMLFWLFLHTPLVIVERHGHAVESFPSTTEDLPCGTDATINEGWLDLKLRNDTDNTFQIEISFDDNFMYGRILSQSSVNIEYTVFNSSVSYFKREEKVYQIASVCRTEKDKMTGSQTEKELYVNQCEIAYKLPDDVKIEERGV	22.06	gnl|BL_ORD_ID|1548|hsp_num:0	1622
NODE_193_length_69652_cov_4.95997_21 # 20155 # 20271 # 1 # ID=193_21;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.333	NODE_193_length_69652_cov_4.95997_21 	20155	20271	+	Strict	700	19.631	vanSI	100.0	3003726	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	ATGGAAAAACAGATACACGGCGGCAATATATTTGATAAAGATATTCTGCTTGACTATTCTGTAAAGAAGCAAGAGGATAACGAATGTCTTATAAAGAATATAATGGAGGTGCAGTAA	MEKQIHGGNIFDKDILLDYSVKKQEDNECLIKNIMEVQ	MAIKLKSEKSKRKNDYSKLKRKLFLQMLLLVSATAATVILMRSVIQKNFSVGDSIVEFLKNTFYLRDSDAVIIYRYIFLHNIEVITFIVILIFLVILLGFSISWFTKYFDEISDGMDKLVGESTAEIALSAELGFMENKLNQIKSNLEKQKKAALEAEQRKNDLVVYLAHDIKTPLTSVIGYLSLLDEAPDMPPEQKAKYVGITLEKAYRLEQLINEFFEITRFNLQTIVLNKEKINLLFMLQQLADEFYPMLTPAQGKQVSVNVPEGLTLWGDADKLARVFNNILKNALAYSYENSVIDISAQKQDKNTVITFTNQGNPIPQEKLETIFEKFFRLDTSRSTNTGGSGLGLAIAKEIANAHGGNIFVQSNSEKTVFTVVLPQKQEKATDRHC	9.69	gnl|BL_ORD_ID|2108|hsp_num:0	2244
NODE_226_length_65892_cov_4.2924_1 # 2 # 487 # -1 # ID=226_1;partial=10;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.327	NODE_226_length_65892_cov_4.2924_1 	2	487	-	Strict	550	322.013	APH(2'')-IIa	99.38	3002635	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(2'')	ATGGTTAACTTGGACGCTGAGATATATGAGCACTTAAATAAACAGATAAAAATAAATGAACTCCGTTATTTATCGTCCGGCGATGATAGTGATACTTTTTTGTGTAATGAACAATATGTTGTGAAAGTTCCTAAACGAGATTCTGTTAGAATTTCTCAGAAACGAGAGTTTGAATTGTATCGTTTTTTAGAAAACTGTAAGCTATCTTATCAAATCCCTGCGGTAGTGTATCAAAGTGACCGATTTAATATTATGAAATATATTAAAGGGGAACGTATTACTTATGAGCAGTATCATAAGTTGAGTGAAAAGGAAAAGGATGCCCTTGCATATGATGAAGCGACGTTTTTGAAAGAGTTACATTCCATAGAGATTGATTGTTCTGTCAGTTTGTTTTCAGATGCTCTGGTGAATAAGAAAGATAAGTTTTTGCAAGATAAAAAATTACTTATAAGCATTCTGGAAAAGGAGCAGCTGTTAACTGAT	MVNLDAEIYEHLNKQIKINELRYLSSGDDSDTFLCNEQYVVKVPKRDSVRISQKREFELYRFLENCKLSYQIPAVVYQSDRFNIMKYIKGERITYEQYHKLSEKEKDALAYDEATFLKELHSIEIDCSVSLFSDALVNKKDKFLQDKKLLISILEKEQLLTD	MVNLDAEIYEHLNKQIKINELRYLSSGDDSDTFLCNEQYVVKVPKRDSVRISQKRELELYRFLENCKLSYQIPAVVYQSDRFNIMKYIKGERITYEQYHKLSEKEKDALAYDEATFLKELHSIEIDCSVSLFSDALVNKKDKFLQDKKLLISILEKEQLLTDEMLEHIETIYENILSNAVLFKYTPCLVHNDFSANNMIFRNNRLFGVIDFGDFNVGDPDNDFLCLLDCSTDDFGKEFGRKVLKYYQHKAPEVAERKAELNDVYWSIDQIIYGYERKDREMLIKDVSELLQTQAEMFIF	54.18	gnl|BL_ORD_ID|1537|hsp_num:0	1615
NODE_280_length_59081_cov_15.5478_15 # 12008 # 12223 # 1 # ID=280_15;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=13bp;gc_cont=0.394	NODE_280_length_59081_cov_15.5478_15 	12008	12223	+	Strict	500	25.0238	aad(6)	100.0	3002628	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(6)	ATGGTATTTAGTAAGTATATACAAAGTCTTCCGAATCAGCAAACTGATACAATAAAACAGATTGCTGACTTGACAAGCTCAACTACTACATCTGTGTATCGCTGGATAGCAGGTAGAGCTCGTCCACCTCTAGTAAAGCAAAAATTGATTGCCGAGTTTCTTGGAATAGAACTGAAGGAACTTTTTCCACCTGAAGAGAAAGGAGGTGAAGCATGA	MVFSKYIQSLPNQQTDTIKQIADLTSSTTTSVYRWIAGRARPPLVKQKLIAEFLGIELKELFPPEEKGGEA	EGSRANINIPKDEFQDYDITYFVSDIEPFISNDDWLNQFGNIIMMQKPEDMELFPPEEKGFSYLMLFDDYNKIDLTLLPLEELDNYLKGDKLIKVLIDKDCRIKRDIVPTDIDYHVRKPSAREYDDCCNEFWNVTPYVIKGLCRKEILFAIDHFNQIVRHELLRMISWKVGIETGFKLSVGKNYKFIERYISEDLWEKLLSTYRMDSYENIWEALFLCHQLFRAVSGEVAERLHYAYPEYDRNITKYTRDMYKKYTGKTGCLDSTYAADIEERREQ	25.72	gnl|BL_ORD_ID|1489|hsp_num:0	1562
NODE_396_length_48823_cov_3.51563_22 # 22386 # 22535 # -1 # ID=396_22;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.427	NODE_396_length_48823_cov_3.51563_22 	22386	22535	-	Loose	700	22.3274	mdtM	28.57	3001214	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; lincosamide antibiotic; nucleoside antibiotic; acridine dye; phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTTTAGGTGGAAGGTGATTCCCGGGATTTCCGACATCATTGAAATTGTCGGAATTTTGCTGGAAGAGATCACCAACTCACTGCTTCCGGTATTTGTTTGGCGTGCATCCAACGATCTTTTTAAAGCAGCTTGTAAAATAACTCTGTGA	MFRWKVIPGISDIIEIVGILLEEITNSLLPVFVWRASNDLFKAACKITL	MPRFFTRHAATLFFPMALILYDFAAYLSTDLIQPGIINVVRDFNADVSLAPAAVSLYLAGGMALQWLLGPLSDRIGRRPVLITGALIFTLACAATMFTTSMTQFLIARAIQGTSICFIATVGYVTVQEAFGQTKGIKLMAIITSIVLIAPIIGPLSGAALMHFMHWKVLFAIIAVMGFISFVGLLLAMPETVKRGAVPFSAKSVLRDFRNVFCNRLFLFGAATISLSYIPMMSWVAVSPVILIDAGSLTTSQFAWTQVPVFGAVIVANAIVARFVKDPTEPRFIWRAVPIQLVGLSLLIVGNLLSPHVWLWSVLGTSLYAFGIGLIFPTLFRFTLFSNKLPKGTVSASLNMVILMVMSVSVEIGRWLWFNGGRLPFHLLAVVAGVIVVFTLAGLLNRVRQHQAAELVEEQ	11.95	gnl|BL_ORD_ID|1141|hsp_num:0	1191
NODE_538_length_40136_cov_4.53429_28 # 35143 # 35997 # -1 # ID=538_28;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.560	NODE_538_length_40136_cov_4.53429_28	35143	35997	-	Strict	400	430.639	ErmX	95.89	3000596	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGTCTGCATACGGACACGGCCGTCACGAACATGGCCAAAATTTTCTCACCGACCACAAGTTCATCAACTCCATCATCGATCTTGTAAAACAAACCTCCGGCCCCATCATTGAGATAGGACCAGGAAGCGGTGCCCTCACTCACCCGATGGCCCACTTGGGGAGGGCGATAACGGCAGTTGAAGTGGACGCAAAACTAGCTGCCAAACTCACACAAGAAACCTCCTCGGCGACGGTCGAAGTGGTCCATGATGATTTCCTTAACTTCCGGTTACCCGCCACTCCCTGCGTCATTGTGGGAAACATTCCCTTTCACCTCACCACTGCCATTCTTCGAAAGTTGCTGCATGCGCCGGCATGGACTGACGCTGTACTCCTCATGCAGTGGGAAGTCGCTCGCCGCCGGGCCGGAGTAGGCGCAAGCACGATGATGACGGCTCAGTGGTCCCCATGGTTCACATTTCACCTTGGTTCCCGGGTACCGAGGTCTGCTTTCCGGCCACAGCCAAACGTTGACGGGGGGATCTTAGTGATCCGCCGGGTGGATGACCCGAAGATTCCGATAAAGCAGCGCAAAGCCTTTCAAGCGATGGTGCACACCGTTTTCACCGCCCGGGGCCGCGGGATAGGGGAAATTCTCCGAAGGGCAGGGATGTTTTCATCACGTTCAGAAACACAATCATGGTTGCGCTCGCGAGGAATCGACCCCGCGACCCTACCTCCCAGATTGTGCACCAGCGACTGGATCGATCTCTTCCAGGTGACTGGTTCCTCTTCACCGCACCATCGACCCATTTCACCATCGGGAAGTAGTCAACGACCTCCTCAACGGAAAAACCGAATCCGGCGGCGTTAA	MSAYGHGRHEHGQNFLTDHKFINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAVEVDAKLAAKLTQETSSATVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRSAFRPQPNVDGGILVIRRVDDPKIPIKQRKAFQAMVHTVFTARGRGIGEILRRAGMFSSRSETQSWLRSRGIDPATLPPRLCTSDWIDLFQVTGSSSPHHRPISPSGSSQRPPQRKNRIRRR	MSAYGHGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAVEVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRPAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRQGCFHHVQKHNHGCAREESTPRPYLPDCTPTTGSISSR	112.25	gnl|BL_ORD_ID|908|hsp_num:0	950
NODE_646_length_35127_cov_34.3726_21 # 24282 # 25172 # 1 # ID=646_21;partial=00;start_type=ATG;rbs_motif=TAAA;rbs_spacer=12bp;gc_cont=0.481	NODE_646_length_35127_cov_34.3726_21	24282	25172	+	Strict	575	594.349	CblA-1	96.28	3002999	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CblA beta-lactamase	ATGAAAGCATATTTCATCGCCATACTTACCTTATTCACTTGTATAGCTACCGTCGTCCGGACGCAGCAAATGTCTGAACTTGAAAACCGGATTGACAGTCTTCTCAATGGCAAGAAAGCCACCGTTGGTATAGCCGTATGGACAGACAAAGGAGACATGCTCCGGTATAACGACCATGTACACTTCCCCTTGCTCAGTGTATTCAAATTCCATGTGGCACTGGCCGTACTGGACAAGATGGATAAGCAAAGCATCAGCCTGGACAGCATTGTTTCCATAAAGGCATCCCAAATGCTGCCCAATACCTACAGCCCCCTGCGGAAGAAGTTTCCCGACCAGGATTTCACGATTACGCTTAGGGAGCTGATGCAATACAGCATTTCCCAAAGCGACAACAATGCCTGCGACATCTTGATAGAATATGCAGGAGGTATCAAACATATCAATGACTATATCCGCCGGTTGGGTATAGACTCCTTCAACCTCTCGGAAACAGAAGACGACATGCACTCCAGCTTCGAGGCTGTATACCGCAACTGGAGTACTCCTTCCGCTATGGCCCAGCTACTGAGAACGGCCGATGAAAAAGAGTTGTTCTCCAACAAGGAACTGAAAGACTTCTTGTGGCAGACCATGATAGATACTGAAACCGGCGCCAACAAATTGAAAGGTATGTTGCCAGCCCAAACCGTGGTAGGACACAAGACCGGTTCTTCCGACCGCAATGCCGACGGTATGAAAACTGCAGATAATGATGCCGGGCTCGTTATTCTTCCCGACGGTCGGAAATACTACATTGCCACCTTCATCATGGACTCATACGAGACGGATGAGGACAATGCAGACATCATCGCCCGCATATCACGCATGGTATATGATGCGATGAGATGA	MKAYFIAILTLFTCIATVVRTQQMSELENRIDSLLNGKKATVGIAVWTDKGDMLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKFPDQDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIRRLGIDSFNLSETEDDMHSSFEAVYRNWSTPSAMAQLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAQTVVGHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIATFIMDSYETDEDNADIIARISRMVYDAMR	MKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNGKKATVGIAVWTDKGDMLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPDQDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSSFEAVYRNWSTPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVVGHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVYDAMR	100.00	gnl|BL_ORD_ID|0|hsp_num:0	2
NODE_841_length_29061_cov_5.30401_2 # 1150 # 1644 # 1 # ID=841_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.335	NODE_841_length_29061_cov_5.30401_2	1150	1644	+	Strict	300	333.183	lnuC	98.17	3002837	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic inactivation	lincosamide nucleotidyltransferase (LNU)	ATGGTCAATATAACAGATGTAAAACAGATTCTTCAATTTGCAATAGATGCGGAGATTAAAGTCTTTCTTGATGGTGGCTGGGGTGTAGATGCTCTTCTTGGATATCAGTCAAGAGCCCATAATGATATTGACATTTTTGTAGAAAAGAACGATTATCAGAACTTTATAGAAATAATGAAAGCTAATGGCTTTTATGAGATTAAGATGGAATATACAACATTGAACCATACTGTATGGGAAGATTTGAAAAACAGAATTATTGATTTGCATTGTTTTGAATATACGGACGAAGGTGAAATTCTTTATGATGGGGATTGTTTTCCGGTAGAAACTTTTTCGGGTAAAGGAAGAATTGAGGAAATAGAGGTTTCCTGTATTGAACCATATAGTCAAGTAATGTTCCATCTGGGATACGAGTTTGATGAAAATGATGCACATGATGTGAAGTTATTGTGTGAGACACTTCATATCGAAATTCCAAATGAGTATAGATAA	MVNITDVKQILQFAIDAEIKVFLDGGWGVDALLGYQSRAHNDIDIFVEKNDYQNFIEIMKANGFYEIKMEYTTLNHTVWEDLKNRIIDLHCFEYTDEGEILYDGDCFPVETFSGKGRIEEIEVSCIEPYSQVMFHLGYEFDENDAHDVKLLCETLHIEIPNEYR	MVNITDVNQIFQFAIDAEIKVFLDGGWGVDALLGYQSRAHNDIDIFVEKNDYQNFIEIMKANGFYEIKMEYTTLNHTVWEDLKNRIIDLHCFEYTDEGEILYDGDCFPVETLSGKGRIEEIEVSCIEPYSQVMFHLGYEFDENDAHDVKLLCETLHIEIPNEYR	100.00	gnl|BL_ORD_ID|352|hsp_num:0	376
NODE_887_length_28107_cov_14.4906_5 # 4430 # 5053 # 1 # ID=887_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.369	NODE_887_length_28107_cov_14.4906_5 	4430	5053	+	Strict	500	24.6386	PEDO-1	100.0	3003670	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	subclass B3 PEDO beta-lactamase	ATGGACATTCGAAAATATCAATTCAATATTTTTTGCCTATTATTGTTTCCCTTATCCACAACAGGACAAGAATGGAACAAACAGGATTCATTGAGACTTCAGCAAATGCTGGAATCCGGTCAGGAGATCAAGATAAATAGAAAGTTTATCGAAAAAGTAGAGCAAAACATGTACTCTCGAAAACCATTCGTAGATTTTGATCCCACACTACCGACTTTAAAATCTTCCATGATTTTTTCGAAACCTTCCATTCGCACTTATCAGACATTCCTAAAACCGGGTTCCACCTTTTTACCCACTTACTCCTGGTTAAGAATAAACAAGAATCTTGTGCTGCACAGTAAAAGTAATTTTGCAGAAAATTCCAGTTGCTTTCATATCCAAAGCCAAATAGAATATAATTTATCTCCCAAATGGTCTCTCAACATATATGGCGTACAAAACCTTGATACCCGAAAACATCGGGGCCTCCCTTCCGAAGTGGAACCCACCCAATTGGGTAGTAATGTTGTTCTCAAAATAAATAAAAACTGGAAAATAAAAACAGGGGTACAATACCAATACAATGTCCTCCGCAAAAGATGGGAATGGATACCTCAAATTAGTGTTTCATACGAATGGTAA	MDIRKYQFNIFCLLLFPLSTTGQEWNKQDSLRLQQMLESGQEIKINRKFIEKVEQNMYSRKPFVDFDPTLPTLKSSMIFSKPSIRTYQTFLKPGSTFLPTYSWLRINKNLVLHSKSNFAENSSCFHIQSQIEYNLSPKWSLNIYGVQNLDTRKHRGLPSEVEPTQLGSNVVLKINKNWKIKTGVQYQYNVLRKRWEWIPQISVSYEW	MKIKFIFCLLLFPLFVFSQNVQEPTDTPKEWSAAYAPFRIVGNVYYVGTYDLACYLITTPKGNILINTGLRSSAAQIKKNVELLGFNFKDIKILLTTQAHYDHLGAMAEIKKLTGAKMMVDEKDASVMKDGGRTDYALGNGKTTYAPIIPDRLLKDGDQIQLGNTSIVMLHHPGHTKGSCSFMLKTKDETRDYSVLIANMPSIVTEKKFSEIPAYPQIEKDYAYTLSSLKKLSFDIWLSSHASQFCLHEKHKPGDKYNPTAFIDRAGYDKVLNSLQLEFDKKIGKK	72.38	gnl|BL_ORD_ID|2097|hsp_num:0	2228
NODE_1091_length_24016_cov_95.7453_27 # 23886 # 24014 # -1 # ID=1091_27;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.512	NODE_1091_length_24016_cov_95.7453_27 	23886	24014	-	Loose	650	21.557	otrC	88.89	3002894	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	CATTACCCTTATGACCACAACATGACACTGGATGCCAATCTCCAGGGCGTGAACGAGCAACTGAACGACCTGGAAGAATACATGGAGGAACAGCAGGAGGCCGAATATAGCGGTGGAATGCGGCGATGA	HYPYDHNMTLDANLQGVNEQLNDLEEYMEEQQEAEYSGGMRR	MTRKTISNGARNAVEVRGLVKHFGEVKAVDGVDLDVREGTVLGVLGPXGAAXXRGALPAHVXGPDAGRRPWRFXTWCANRRALRRTIGXHRPVRXGRRESFSGRENLYMIGRXLDLSRKDARARADELLERFSLTEAAGRAAAKYSGGMRRRLDLAASMIGRPAVLYLDEPTTGLDPRTRNEVWDEVRSMVRDGATVLLTTQYMEEAEQLAHELTVIDRGRVIADGKVDELKTKVGGRTLQIRPAHAAELDRMVGAIAQAGLDGIAGATADHEDGVVNVPIVSDEQLSAVVGMLGERGFTISGHQHPSAQLXEVFLAITGQKTSEAADGGPQDGPQDQQGVQDKQYEEVPA	11.97	gnl|BL_ORD_ID|1905|hsp_num:0	1991
NODE_1155_length_23000_cov_2.59773_4 # 3651 # 3869 # 1 # ID=1155_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.575	NODE_1155_length_23000_cov_2.59773_4 	3651	3869	+	Loose	400	22.7126	ErmX	37.04	3000596	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGCGGCAAGCAGGACACCCAGGAGCCCCGCCCAAGGTGGAAATTGACTACGGCAATTCCGAACTCTACACCCAGGAGGACATGGACGCTGCCATCCAGGTAATTGAAGCGGAGTTTGCCACCTGGGAAGGCTGTGAACTTCACAGCCTGGCCTACGGCGGCGACGCGGCCTGCAGCGACGAAAACATTGAGTGGCTCAATGTTTTCGGCTGGAAATGA	MRQAGHPGAPPKVEIDYGNSELYTQEDMDAAIQVIEAEFATWEGCELHSLAYGGDAACSDENIEWLNVFGWK	MSAYGHGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAVEVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRPAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRQGCFHHVQKHNHGCAREESTPRPYLPDCTPTTGSISSR	28.46	gnl|BL_ORD_ID|908|hsp_num:0	950
NODE_1315_length_20626_cov_8.66725_19 # 19020 # 20018 # 1 # ID=1315_19;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.457	NODE_1315_length_20626_cov_8.66725_19 	19020	20018	+	Strict	500	24.2534	APH(6)-Ic	100.0	3002659	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(6)	ATGATAACAGGTACAATTATTACTTTTCTCCAGCGTGCTGTAATGCAGGGTATTCCGCTGCTTTTCGGCTCAACGGGTGAAATTATGACAGAAAAATCAGGCAACCTTAATCTTGGTATACCCGGTATTATGTATGTTGGGGGTATCAGCGGTGTTATCGGTGCGTTCTTTTATGAAAACTCGCTGGCAAGTCCTGATGATGCAAACGGCTTTCTTGCAGTAATGATTCCGCTTCTTTGCTGTCTGCTGGGCTCATTGCTCATGGGACTCCTGTACTGCTTCCTTACGGTTACGCTCCGTGCAAATCAGAATGTAACAGGTCTTGCACTTACCACCTTCGGTGTGGGTTTTGGTAACTTTTTCGGAGGCTCGCTTATTAAGCTGACAGGTGCAGATGTGCCCTCCGTTGCTCTGACTACAACAAGCAACTTTTTCAGGCAATCTCTGCCAGGTGCAAAAACTACAGGCTGGTTTGGCGAAGCGTTTTTGTCCTATGGTTTTCTTGCCTATGCAGCAGTAATTATTGCAATCGCCTGTGCCTTTTTCCTTAAAAGGACAAAGGGCGGTCTTCACCTTCGTGCGGTTGGTGAAAATCCTGCAACAGCGGACGCAGCAGGTATTAATGTCAACAGGTCGAAATATCTTGCAACCTGTATCGGCAGTATGATTGCAGGTCTGGGCGGTCTTTACTACGTTATGGACTATGCCTGCGGCGTGTGGTCAAATGAGGGATTCGGCGACAGAGGCTGGCTTGCTATCGCACTTGTAATTTTTGCAATCTGGCGTCCTAATATGGGCATATTCGGCTCAATTATCTTCGGCGGCTTGTATATTGTTTATCTCTTTATACCGGGTCTGGCACTGCGCACACAGGAGCTTTTCAAAATGCTTCCGTATATTGTAACGATTATTGTTTTGATTTTTGTAAGCATTAAGAATAAAAAGGAAAACTGCGGACCGCAGTCCCTGGGCTTATCCTATTTCAGAGAAGAGCGATAA	MITGTIITFLQRAVMQGIPLLFGSTGEIMTEKSGNLNLGIPGIMYVGGISGVIGAFFYENSLASPDDANGFLAVMIPLLCCLLGSLLMGLLYCFLTVTLRANQNVTGLALTTFGVGFGNFFGGSLIKLTGADVPSVALTTTSNFFRQSLPGAKTTGWFGEAFLSYGFLAYAAVIIAIACAFFLKRTKGGLHLRAVGENPATADAAGINVNRSKYLATCIGSMIAGLGGLYYVMDYACGVWSNEGFGDRGWLAIALVIFAIWRPNMGIFGSIIFGGLYIVYLFIPGLALRTQELFKMLPYIVTIIVLIFVSIKNKKENCGPQSLGLSYFREER	MERWRLLRDGELLTTHSSWILPVRQGDMPAMLKVARIPDEEAGYRLLTWWDGQGAARVFASAAGALLMERASGAGDLAQIAWSGQDDEACRILCDTAARLHAPRSGPPPDLHPLQEWFQPLFRLAAEHAALAPAASVARQLLAAPREVCPLHGDLHHENVLDFGDRGWLAIDPHGLLGERTFDYANIFTNPDLSDPGRPLAILPGRLEARLSIVVATTGFEPERLLRWIIAWTGLSAAWFIGDGDGEGEGAAIDLAVNAMARRLLD	124.81	gnl|BL_ORD_ID|856|hsp_num:0	892
NODE_1359_length_20009_cov_3.07547_22 # 19932 # 20009 # 1 # ID=1359_22;partial=01;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.449	NODE_1359_length_20009_cov_3.07547_22 	19932	20009	+	Strict	450	20.0162	ANT(4')-Ib	100.0	3003905	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(4')	ATGCCCAATTTACGCTGTGAATTGCACCACAGAATCTGCAATTTACGTTATGGAACTCACGGTTATGGGATGAGTGCC	MPNLRCELHHRICNLRYGTHGYGMSA	MNGPIIMTREERMKIVHEIKERILDKYGDDVKAIGVYGSLGRQTDGPYSDIEMMCVMSTEEAEFSHEWTTGEWKVEVNFDSEEILLDYASQVESDWPLTHGQFFSILPIYDSGGYLEKVYQTAKSVEAQTFHDAICALIVEELFEYAGKWRNIRVQGPTTFLPSLTVQVAMAGAMLIGLHHRICYTTSASVLTEAVKQSDLPSGYDHLCQFVMSGQLSDSEKLLESLENFWNGIQEWTERHGYIVDVSKRIPF	10.28	gnl|BL_ORD_ID|2189|hsp_num:0	2383
NODE_1439_length_19193_cov_2.74679_34 # 18422 # 18595 # -1 # ID=1439_34;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.569	NODE_1439_length_19193_cov_2.74679_34 	18422	18595	-	Loose	700	23.0978	ADC-82	50.0	3003888	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamase	ATGGCTACTTTGGATGTTACGGAGAAGGTCAACGTCCTCATGGACGCGATTGGCTGGGAGAGTTTTTGCGAAGAGCTGATGGAACGGATGGACGAGGACGCTCTCGATGCCGTCTGCGACCGTATCGCACCGCGTTACGGCGTGGAGCTTGCGGGGAGTCGCTATGCAGCCTAA	MATLDVTEKVNVLMDAIGWESFCEELMERMDEDALDAVCDRIAPRYGVELAGSRYAA	MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDALAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK	14.88	gnl|BL_ORD_ID|2365|hsp_num:0	2371
NODE_1541_length_18179_cov_3.3715_12 # 18112 # 18177 # 1 # ID=1541_12;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.500	NODE_1541_length_18179_cov_3.3715_12 	18112	18177	+	Strict	2200	18.4754	Bifidobacterium ileS conferring resistance to mupirocin	100.0	3003730	protein homolog model	n/a	n/a	mupirocin	antibiotic target alteration	antibiotic resistant isoleucyl-tRNA synthetase (ileS)	ATGGTCACGCCCGATCATTCGCAGAATGAAATCAACGGTACCGTCGATTCCATAGCTTGCGCTGTT	MVTPDHSQNEINGTVDSIACAV	MSETTNSHVYPKANEGGETASVAPNPSFPNMEETVLKYWDKDDTFNKSVERNPSGDHSQNEFVFFDGPPFANGLPHYGHLLTGYAKDVIPRYQTMKGRKVNRVFGWDTHGLPAELEAQKELGIDSVDQIEKMGIDKFNDACRASVLKYTHEWQDYVHRQARWVDFEHGYKTLNIPYMESVMWAFKQLYEKGLAYQGYRVLPYCPKDQTPLSAHELRMDADVYQDRQDTTVSVAVKLRDEEDAYAVFWTTTPWTVPTNFAIVVGADIDYVEVRPTQGKYAGKKFYFGKPLLSKYEKELGEDYEVVRELKGSEMAGWRYWPVFPYFAGDKAESEGNVPGPEGYQIFTADYVDTVEGTGLVHQAPYGEDDMNTLNAHGIKSTDVLDAGCRFTAQCPDYEGMYVFDANKPILRNLRNGDGPLAEIPAEHRAILFQEKSYVHSYPHCWRCATPLIYKPVSSWFVSVTKIKPRLLELNQQINWIPENVKDGQFGKWLANARDWSISRNRFWGSPIPVWVSDDPKYPRVDVYGSLEELKADFGDYPRDKDGNVNMHRPWIDNLTRVNPDDPTGKSHMHRISDVLDCWFESGSMSFAQFHYPFENKEKFEQHFPADYIVEYIGQTRGWFYLLHVMATALFDRPAFKNVICHGIVLGSDGQKMSKHLRNYPDVNGVFDKYGSDAMRWFLMSSPILRGGNLIVTAEGIRDTVRQVMLPVWSSYYFFTLYANAANGGAGFDARQLRADEVAGLPEMDRYLLARTRRLVERVEKSLDEFAISDACDAASDFIDVLTNWYIRNTRDRFWKEDVNAFNTLYTVLEVFMRVLAPLAPMESESVWRGLTGGESVHLADWPYVADEKTGEATELGRVLVDDPALVDAMEKVREIVSGALSLRKAAQIRVRQPLAKLTVVVEDVDAVKAYDEILKSELNIKDIEFCTMEDAGSQGLKIVHELKVNARAAGPRLGKQVQFAIKASKTGAWHVDAATGAPVVETPNGEVALEAGEYELINRVEEENAAEADASVSAALPTGGFVILDTVLTADLEAEGYARDVIRAVQDARKAADLDIADRIALVLTVPSANVADVERFRDLIAHETLATSFAVKEGAELGVEVAKA	1.99	gnl|BL_ORD_ID|2128|hsp_num:0	2278
NODE_1678_length_16815_cov_23.8758_18 # 15597 # 16814 # 1 # ID=1678_18;partial=01;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.389	NODE_1678_length_16815_cov_23.8758_18 	15597	16814	+	Strict	1200	819.691	tetO	99.01	3000190	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAAAATAATTAACTTAGGCATTCTGGCTCACGTTGACGCAGGAAAGACAACATTAACGGAAAGTTTATTGTATACCAGTGGTGCAATTGCAGAACTAGGGAGCGTAGATGAAGGCACAACAAGGACAGATACAATGAATTTGGAGCGTCAAAGGGGAATCACTATCCAGACAGCAGTGACATCTTTTCAGTGGGAGGATGTAAAAGTCAACATTATAGATACGCCAGGCCATATGGATTTTTTGGCGGAAGTATACCGTTCTTTATCCGTATTAGACGGAGCAGTATTATTAGTTTCTGCAAAGGATGGCATACAGGCACAGACCCGTATACTGTTTCATGCACTACAGATAATGAAGATTCCGACAATTTTTTTCATCAATAAAATTGACCAAGAGGGGATTGATTTGCCAATGGTATATCGGGAAATGAAAGCAAAGCTTTCTTCGGAAATTATAGTGAAGCAAAAGGTTGGGCAGCATCCCCATATAAATGTAACGGACAATGACGATATGGAACAGTGGGATGCGGTAATTATGGGAAACGATGAACTATTAGAGAAATATATGTCAGGGAAACCGTTTAAAATGTCAGAACTGGAACAGGAAGAAAACAGGAGATTCCAAAACGGAACGTTATTTCCCGTTTATCACGGAAGCGCTAAAAACAATCTGGGGATTCGGCAGCTTATAGAAGTAATTGCCAGTAAATTTTATTCATCAACGCCTGAAGGTCAATCTGAACTATGCGGGCAGGTTTTTAAGATTGAATATTCAGAGAAAAGGCGGCGTTTTGTTTATGTGCGTATATATAGCGGAACATTGCATTTGAGGGATGTTATTAGAATATCTGAAAAAGAGAAAATAAAAATCACAGAGATGTGTGTTCCGACAAACGGTGAATTATATTCATCCGATACAGCCTGCTCTGGTGATATTGTAATTTTACCAAATGATGTTTTGCAGCTAAACAGTATTTTGGGGAACGAAATACTGTTGCCGCAGAGAAAATTTATTGAAAATCCTCTCCCTATGCTCCAAACAACGATTGCAGTAAAGAAATCTGAACAGCGGGAAATATTGCTTGGGGCACTTACAGAAATTTCAGATGGCGACCCTCTTTTAAAATATTATGTGGATACTACAACGCATGAGATTATACTTTCTTTTTTGGGGAATGTGCAGATGGAAGTCATTTGTGCCATCCTTGAGGAAAAA	MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAVTSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMKIPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIMGNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYSSTPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCVPTNGELYSSDTACSGDIVILPNDVLQLNSILGNEILLPQRKFIENPLPMLQTTIAVKKSEQREILLGALTEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEK	MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAVTSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMKIPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIMGNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGTRQLIEVIASKFYSSTPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMYVPTNGELYSSDTACSGDIVILPNDVLQLNSILGNEILLPQRKFIENPLPMIQTTIAVKKSEQREILLGALTEISDCDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIYMERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEGVLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYLHFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQGVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA	63.54	gnl|BL_ORD_ID|1931|hsp_num:0	2020
NODE_1899_length_15155_cov_4.51166_1 # 1 # 474 # 1 # ID=1899_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.319	NODE_1899_length_15155_cov_4.51166_1 	1	474	+	Strict	550	322.013	APH(2'')-IIa	98.73	3002635	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(2'')	TTTTTGCAAGATAAAAAATTACTTATAAGTATTCTGGAAAAGGAGCAGCTGTTAACTGATGAGATGTTGGAACATATCGAAACAATATATGAAAACATATTAAACAATGCTGTTTTATTTAAATATACCCCTTGTTTGGTACATAATGATTTCAGTGCAAATAACATGATTTTTAGAAATAATAGACTGTTTGGAGTTATTGATTTTGGCGATTTTAATGTAGGTGACCCGGATAATGATTTTTTGTGCTTGCTGGATTGTAGTACAGATGATTTCGGGAAAGAATTTGGCAGGAAGGTATTAAAATACTATCAGCATAAGGCGCCGGAAGTAGCAGAAAGAAAAGCAGAGCTTAATGATGTATATTGGTCGATAGACCAAATTATTTATGGTTATGAAAGAAAAGATAGGGAAATGTTGATTAAGGGTGTTTCTGAATTGCTACAAACACAAGCAGAGATGTTTATATTTTAG	FLQDKKLLISILEKEQLLTDEMLEHIETIYENILNNAVLFKYTPCLVHNDFSANNMIFRNNRLFGVIDFGDFNVGDPDNDFLCLLDCSTDDFGKEFGRKVLKYYQHKAPEVAERKAELNDVYWSIDQIIYGYERKDREMLIKGVSELLQTQAEMFIF	MVNLDAEIYEHLNKQIKINELRYLSSGDDSDTFLCNEQYVVKVPKRDSVRISQKRELELYRFLENCKLSYQIPAVVYQSDRFNIMKYIKGERITYEQYHKLSEKEKDALAYDEATFLKELHSIEIDCSVSLFSDALVNKKDKFLQDKKLLISILEKEQLLTDEMLEHIETIYENILSNAVLFKYTPCLVHNDFSANNMIFRNNRLFGVIDFGDFNVGDPDNDFLCLLDCSTDDFGKEFGRKVLKYYQHKAPEVAERKAELNDVYWSIDQIIYGYERKDREMLIKDVSELLQTQAEMFIF	52.51	gnl|BL_ORD_ID|1537|hsp_num:0	1615
NODE_1899_length_15155_cov_4.51166_2 # 518 # 1054 # 1 # ID=1899_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.400	NODE_1899_length_15155_cov_4.51166_2	518	1054	+	Perfect	275	368.622	AAC(6')-Ip	100.0	3002559	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGTTGGAAAAAAAGCGAGTTTCCTTTCGCCCGATGAATGAGGATGATTTAGTTCTAATGCTAAAATGGCTGACAGATGACCGTGTTCTTGAATTCTACGACGGTAGAGATAAAAAACATACACAGAAAACGATTCGTGAGCATTATACAGAGCAATGGGCGGATGAGATTTATCGAGTCATCATTGAATATGATACAATTCCTATCGGTTACGCACAAATATATAGAATTCAGGGGGAACTTTTCGACGAATATAATTACCATGAGACGGAAGAAAAGATTTATGCGATGGACCAATTTATCGGTGAGCCGGAATATTGGAATATGGGAATCGGTGCAGAATATTGCAGAGTAGTATGCCAATATCTACGAACGGAAATGGATGCCGATGCGGTGATTCTTGACCCACGAAAAAATAATCTACGAGCAGTACGAGCATATCAGAAGGCAGGATTTAAAATTATTAAGGAACTTCCCGAACATGAGCTACACGAGGGGAAAAAGGAAGATTGTGTGCTGATGGAATGGAGAGTGTAA	MLEKKRVSFRPMNEDDLVLMLKWLTDDRVLEFYDGRDKKHTQKTIREHYTEQWADEIYRVIIEYDTIPIGYAQIYRIQGELFDEYNYHETEEKIYAMDQFIGEPEYWNMGIGAEYCRVVCQYLRTEMDADAVILDPRKNNLRAVRAYQKAGFKIIKELPEHELHEGKKEDCVLMEWRV	MLEKKRVSFRPMNEDDLVLMLKWLTDDRVLEFYDGRDKKHTQKTIREHYTEQWADEIYRVIIEYDTIPIGYAQIYRIQGELFDEYNYHETEEKIYAMDQFIGEPEYWNMGIGAEYCRVVCQYLRTEMDADAVILDPRKNNLRAVRAYQKAGFKIIKELPEHELHEGKKEDCVLMEWRV	100.00	gnl|BL_ORD_ID|1580|hsp_num:0	1653
NODE_2050_length_13893_cov_18.0556_7 # 6449 # 6592 # 1 # ID=2050_7;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.306	NODE_2050_length_13893_cov_18.0556_7 	6449	6592	+	Loose	1300	21.1718	optrA	52.63	3003746	protein homolog model	n/a	n/a	oxazolidinone antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGATTTTAGCAATTAAGAGCAATCACCCAAGTTTTAAAACGGTAAAACTAAATAAAGGGTATAATATTATAGTAGCTGATCGAATAAACGATGTTGCAAATGGTAAGCTAAAATCTAGAAATGGGGCAGGAAAAACAACATAA	MILAIKSNHPSFKTVKLNKGYNIIVADRINDVANGKLKSRNGAGKTT	MSKATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKTTLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDMENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADYKKPISEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRMFLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFRYKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTPLAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMGGVAALSGDFKFGYNVEISYFDQQLAQISGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKRTNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFVQSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQYDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM	7.18	gnl|BL_ORD_ID|2139|hsp_num:0	2263
NODE_2101_length_13582_cov_64.1782_12 # 11000 # 11800 # -1 # ID=2101_12;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=3bp;gc_cont=0.355	NODE_2101_length_13582_cov_64.1782_12	11000	11800	-	Strict	400	486.108	ErmF	89.47	3000498	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACAAAAAAGAAATTGCCCGTTCGTTTCACGGGTCAGCACTTTACCATTGATAAAGTGCTAATAGAAGATGCAATAAAACAAGCAAATATAAATAGTCAGGATACGGTTTTGGATATTGGGGCAGGCAAGGGATTTCTCACTGTCCATTTATTAAAAATCGCCAACATTGTCGTAGCTATTGAAAACGACACAGCTTTGGTTGAATATTTACGAAAATTATTTTCTGATGCCCGCAATGTTCAAATTGTCGGTTGTGATTTTAGGAATTTTGCAGTTCCCAAGTTTCCTTTCAAGGTGGTGTCAAACATTCCTTATGGAATTACTTCCGATATATTCAAAATTCTGATGTTTGAGAGTGTTGAAAATTTTCTCGGAGGTTCCATTGTCCTTCAGTTAGAACCTGCTCAAAAGTTGTTTTCGAGTAAGCTCTATAATCCATATACTGTTTTCTATCATACTTTTTTTGATTTGAAACTTGTCTATGAGGTAAGTCCTGAAAGTTTCTTGCCACCACCAACTGTCAAATCAACTCTGTTACGCATTAAAAGAAATCAGTCTTCTTTTGATTTTGAGCTTAAAGTCAAATATTTAGCTTTTATTTCCTGTCTGTTACAGAAGCCTGATTTATCTGTCAAAACAGCTTTAAAGTCGATTTTCAGAAAAAATCAGGTCAGGTCAATTTCGGAAAAATTCGGAATAAACCTTAACTCCCAAATTGTCTGTTTGTCGCCAAGTCAATGGAAAAACTGTTTTTTGGAAATGCTGGAAGTTGCCCCCGAAAAGTTTCACCCTTCATAA	MTKKKLPVRFTGQHFTIDKVLIEDAIKQANINSQDTVLDIGAGKGFLTVHLLKIANIVVAIENDTALVEYLRKLFSDARNVQIVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFESVENFLGGSIVLQLEPAQKLFSSKLYNPYTVFYHTFFDLKLVYEVSPESFLPPPTVKSTLLRIKRNQSSFDFELKVKYLAFISCLLQKPDLSVKTALKSIFRKNQVRSISEKFGINLNSQIVCLSPSQWKNCFLEMLEVAPEKFHPS	MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVAIENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFESLGNFLGGSIVLQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFLPPPTVKSALLNIKRKHLFFDFKFKAKYLAFISYLLEKPDLSVKTALKSIFRKSQVRSISEKFGLNLNAQIVCLSPSQWLNCFLEMLEVVPEKFHPS	100.00	gnl|BL_ORD_ID|586|hsp_num:0	621
NODE_2105_length_13557_cov_17.083_1 # 2 # 127 # 1 # ID=2105_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.381	NODE_2105_length_13557_cov_17.083_1 	2	127	+	Loose	2090	19.631	cmeB	52.0	3000784	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; cephalosporin; fusidic acid	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATCGGAAATATTTGTTTGTTTGCTGTGTCTTCCCTGCACTGTGAAGTGCGGGGAGCACTATTTTATACAGACCTATATTTTCAAACCCAAAACAACCGTAACAAAGAACTCTTGGATGTTCATTAA	IGNICLFAVSSLHCEVRGALFYTDLYFQTQNNRNKELLDVH	MFSKFFIERPVFASVVAIIISLAGVIGLTNLPIEQYPSLTPPTVKVSATYTGADAQTIASTVASPIEDAINGADNMIYMDSTSSSSGTMSLTVYFDIGTDPDQATIDVNNRISAATAKMPDAVKKLGVTVRKTSSATLAAISMYSSDGSMSAVDVYNYIALNVLDELKRVPGVGDANAIGNRNYSLRIWLKPDLLNKFKITATDVISAVNDQNAQYATGKIGEEPVTQKSPYVYSITMQGRLQNPSEFENIILRTNDDGSFLRLKDIADVEIGSQQYSSQGRLNGNDAVPIIINLQSGANALHTAELVQAKMQELSKNFPKGLTYKIPYDTTKFVIESIKEVIKTFIEALILVIIVMYMFLKNFRATLIPMIAVPVSLLGTFAGLYVLGFSINLLTLFALILAIGIVVDDAIIVVENIDRILHENEQISVKDAAIQAMQEVSSPVISIVLVLCAVFIPVSFISGFVGEIQRQFALTLAISVTISGFVALTLTPSLCALFLRRNEGEPFKFVRKFNDFFDWSTSVFSAGVAYILKRTIRFVLIFCIMLGTIFYLNKAVPNSLVPEEDQGLMIGIINLPSASALHRTISEVDHISQEVLKTNGIKDAMAMIGFDLFTSSLKENAAAMFIGLQDWKDRNVSADKIAMELNKKFAFDRNASSIFIGLPPIPGLSITGGFEMYVQNKSGKSYDQIQKDVNKLVAAANQRKELSRVRTTLDTTFPQYKLIIDRDKLKHYNLNMQDVFNTMNATIGTYYVNDFSMLGKNFQVNIRAKGDFRNTQDALKNIFVRSNDGKMIPLDSFLTLQRSSGPDDVKRFNLFPAAQVQGQPAPGYTSGQAIEAIAQVAKETLGDDYSIAWSGSAYQEVSSKGTASYAFALGMIFVFLILAAQYERWLIPLAVVTAVPFAVFGSFLLVYLRGFSNDIYFQTGLLLLIGLSAKNAILIVEFAMEERFKKGKGVFEAAVAAAKLRFRPIIMTSLAFTFGVLPMIFATGAGSASRHSLGTGLIGGMIAASTLAIFFVPLFFYLLENFNEWLDKKRGKIHE	3.94	gnl|BL_ORD_ID|707|hsp_num:0	748
NODE_2300_length_12428_cov_279.283_2 # 428 # 2353 # -1 # ID=2300_2;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=5bp;gc_cont=0.397	NODE_2300_length_12428_cov_279.283_2	428	2353	-	Strict	1200	1287.71	tetQ	97.04	3000191	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAATATTATAAATTTAGGAATTCTTGCTCACATTGATGCAGGAAAAACTTCCGTAACCGAGAATCTGCTGTTTGCCAGTGGAGCAACGGAAAAGTGCGGCCGTGTGGATAATGGTGACACCATAACAGACTCTATGGATATAGAGAAACGTAGAGGAATTACTGTTCGGGCTTCTACGACATCTATTATCAGGAATGGTGTGAAATGCAATATCATTGACACTCCGGGACACATGGATTTTATTGCGGAAGTGGAGCGGACATTCAAAATGCTTGATGGAGCAGTCCTCATCTTATCCGCAAAGGAAGGCATACAAGCGCAGACAAAGTTGCTGTTCAGTACTTTACAAAAGCTGCAAATCCCGACAATTATATTTATCAATAAGATTGACCGTGCCGGTGTGAATTTGGAGCGTTTGTATCTGGATATAAAAACAAATCTGTCGCAAGATGTCCTGTTTATGCAAACTGTTGTCGATGGATCGGTTTATCCGATTTGCTCCCAAACATATATAAAGGAAGAATACAAAGAATTTGTATGCAACCATGACGACGATATATTAGAACGATATTTGGCGGATAGCGAAATTTCACCGGCTGATTATTGGAATACGATAATCGCTCTTGTGGCAAAAGCCAAAGTCTATCCGGTGCTACATGGATCAGCAATGTTCAATATCGGTATCAATGAGTTGTTGGACGCCATTTCTTCTTTTATACTTCCTCCGGCATCAGTCTCAAACAGACTTTCAGCTTATCTCTATAAGATAGAGCATGACCCCAAAGGGCATAAAAGAAGTTTTCTTAAAATAATTGACGGAAGTCTGAGACTTCGAGACGTTGTAAGAATCAACGATTCGGAAAAATTCATCAAGATTAAAAATCTAAAGACTATTTATCAGGGCAGAGAGATAAATGTTGATGAAGTGGGTGCCAATGATATCGCGATTGTAGAAGATATAGAAGATTTTCGAATCGGAGATTATTTAGGTGCTAAACCTTGTTTGATTCAAGGATTATCTCATCAGCATCCCGCTCTCAAATCCTCCGTCCGGCCAAATAAGCCCGAAGAGAGAAGCAAGGTGATATCCGCTCTGAATACATTGTGGATTGAAGACCCGTCTTTGTCCTTTTCCATAAACTCATATAGTGATGAATTGGAAATCTCGTTATATGGTTTGACCCAAAAGGAAATCATACAGACATTGCTGGAAGAACGATTTTCCGTAAAGGTCCATTTTGATGAGATCAAGACTATCTACAAAGAACGACCTATAAAAAAGGTCAATAAGATTATTCAGATCGAAGTACCACCCAACCCTTACTGGGCCACAATAGGGCTGACTCTTGAACCCTTACCGTTAGGGGCAGGGTTGCAAATCGAAAGTGACATCTCCTATGGTTATCTGAACCATTCTTTTCAAAATGCCGTTTTTGAAGGGATTCGTATGTCTTGCCAATCTGGTTTACATGGATGGGAAGTGACAGATCTGAAAGTAACTTTTACTCAAGCCGAGTATTATAGCCCGGTAAGTACACCTGCTGATTTCAGACAGCTGACCCCTTATGTCTTCAGGCTGGCCTTGCAACAGTCAGGTGTGGACATTCTCGAACCGATGCTCTATTTTGAGTTGCAGATACCCCAAGCGGCAAGTTCCAAAGCTATTACAGATTTGCAAAAAATGATGTCTGAGATTGAAGACATCAGTTGCAATAATGAGTGGTGTCATATTAAAGGGAAAGTTCCATTAAATACAAGTAAAGACTATGCCTCAGAAATAAGTTCATACACTAAGGGCTTAGGCATTTTTATGGTTAAGCCATGCGGGTATCAAATAACAAAAGGCGGTTATTCTGATAATATCCGCATGAACGAAAAAGATAAACTTTTATTCATGTTCCAAAAATCAATGTCATTAAAATAA	MNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRASTTSIIRNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFSTLQKLQIPTIIFINKIDRAGVNLERLYLDIKTNLSQDVLFMQTVVDGSVYPICSQTYIKEEYKEFVCNHDDDILERYLADSEISPADYWNTIIALVAKAKVYPVLHGSAMFNIGINELLDAISSFILPPASVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKFIKIKNLKTIYQGREINVDEVGANDIAIVEDIEDFRIGDYLGAKPCLIQGLSHQHPALKSSVRPNKPEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTIYKERPIKKVNKIIQIEVPPNPYWATIGLTLEPLPLGAGLQIESDISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPMLYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEISSYTKGLGIFMVKPCGYQITKGGYSDNIRMNEKDKLLFMFQKSMSLK	MRFDNASIVVYYCLIQMNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRASTTSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQIPTIIFINKIDRDGVNLERLYLDIKTNLSQDVLFMQTVVDGLVYPICSQTYIKEEYKEFVCNHDDNILERYLADSEISPADYWNTIIDLVAKAKVYPVLHGSAMFNIGINELLDAISSFILPPESVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDIVRINDSEKFIKIKNLKTIYQGREINVDEVGANDIAIVEDMEDFRIGDYLGTKPCLIQGLSHQHPALKSSVRPDRSEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTIYKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPMLYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKGLGVFMVKPCGYQITKGDYSDNIRMNEKDKLLFMFQKSMSSK	97.56	gnl|BL_ORD_ID|1133|hsp_num:0	1183
NODE_2300_length_12428_cov_279.283_13 # 9007 # 10932 # -1 # ID=2300_13;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=5bp;gc_cont=0.397	NODE_2300_length_12428_cov_279.283_13	9007	10932	-	Strict	1200	1287.71	tetQ	97.04	3000191	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAATATTATAAATTTAGGAATTCTTGCTCACATTGATGCAGGAAAAACTTCCGTAACCGAGAATCTGCTGTTTGCCAGTGGAGCAACGGAAAAGTGCGGCCGTGTGGATAATGGTGACACCATAACAGACTCTATGGATATAGAGAAACGTAGAGGAATTACTGTTCGGGCTTCTACGACATCTATTATCAGGAATGGTGTGAAATGCAATATCATTGACACTCCGGGACACATGGATTTTATTGCGGAAGTGGAGCGGACATTCAAAATGCTTGATGGAGCAGTCCTCATCTTATCCGCAAAGGAAGGCATACAAGCGCAGACAAAGTTGCTGTTCAGTACTTTACAAAAGCTGCAAATCCCGACAATTATATTTATCAATAAGATTGACCGTGCCGGTGTGAATTTGGAGCGTTTGTATCTGGATATAAAAACAAATCTGTCGCAAGATGTCCTGTTTATGCAAACTGTTGTCGATGGATCGGTTTATCCGATTTGCTCCCAAACATATATAAAGGAAGAATACAAAGAATTTGTATGCAACCATGACGACGATATATTAGAACGATATTTGGCGGATAGCGAAATTTCACCGGCTGATTATTGGAATACGATAATCGCTCTTGTGGCAAAAGCCAAAGTCTATCCGGTGCTACATGGATCAGCAATGTTCAATATCGGTATCAATGAGTTGTTGGACGCCATTTCTTCTTTTATACTTCCTCCGGCATCAGTCTCAAACAGACTTTCAGCTTATCTCTATAAGATAGAGCATGACCCCAAAGGGCATAAAAGAAGTTTTCTTAAAATAATTGACGGAAGTCTGAGACTTCGAGACGTTGTAAGAATCAACGATTCGGAAAAATTCATCAAGATTAAAAATCTAAAGACTATTTATCAGGGCAGAGAGATAAATGTTGATGAAGTGGGTGCCAATGATATCGCGATTGTAGAAGATATAGAAGATTTTCGAATCGGAGATTATTTAGGTGCTAAACCTTGTTTGATTCAAGGATTATCTCATCAGCATCCCGCTCTCAAATCCTCCGTCCGGCCAAATAAGCCCGAAGAGAGAAGCAAGGTGATATCCGCTCTGAATACATTGTGGATTGAAGACCCGTCTTTGTCCTTTTCCATAAACTCATATAGTGATGAATTGGAAATCTCGTTATATGGTTTGACCCAAAAGGAAATCATACAGACATTGCTGGAAGAACGATTTTCCGTAAAGGTCCATTTTGATGAGATCAAGACTATCTACAAAGAACGACCTATAAAAAAGGTCAATAAGATTATTCAGATCGAAGTACCACCCAACCCTTACTGGGCCACAATAGGGCTGACTCTTGAACCCTTACCGTTAGGGGCAGGGTTGCAAATCGAAAGTGACATCTCCTATGGTTATCTGAACCATTCTTTTCAAAATGCCGTTTTTGAAGGGATTCGTATGTCTTGCCAATCTGGTTTACATGGATGGGAAGTGACAGATCTGAAAGTAACTTTTACTCAAGCCGAGTATTATAGCCCGGTAAGTACACCTGCTGATTTCAGACAGCTGACCCCTTATGTCTTCAGGCTGGCCTTGCAACAGTCAGGTGTGGACATTCTCGAACCGATGCTCTATTTTGAGTTGCAGATACCCCAAGCGGCAAGTTCCAAAGCTATTACAGATTTGCAAAAAATGATGTCTGAGATTGAAGACATCAGTTGCAATAATGAGTGGTGTCATATTAAAGGGAAAGTTCCATTAAATACAAGTAAAGACTATGCCTCAGAAATAAGTTCATACACTAAGGGCTTAGGCATTTTTATGGTTAAGCCATGCGGGTATCAAATAACAAAAGGCGGTTATTCTGATAATATCCGCATGAACGAAAAAGATAAACTTTTATTCATGTTCCAAAAATCAATGTCATTAAAATAA	MNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRASTTSIIRNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFSTLQKLQIPTIIFINKIDRAGVNLERLYLDIKTNLSQDVLFMQTVVDGSVYPICSQTYIKEEYKEFVCNHDDDILERYLADSEISPADYWNTIIALVAKAKVYPVLHGSAMFNIGINELLDAISSFILPPASVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKFIKIKNLKTIYQGREINVDEVGANDIAIVEDIEDFRIGDYLGAKPCLIQGLSHQHPALKSSVRPNKPEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTIYKERPIKKVNKIIQIEVPPNPYWATIGLTLEPLPLGAGLQIESDISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPMLYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEISSYTKGLGIFMVKPCGYQITKGGYSDNIRMNEKDKLLFMFQKSMSLK	MRFDNASIVVYYCLIQMNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRASTTSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQIPTIIFINKIDRDGVNLERLYLDIKTNLSQDVLFMQTVVDGLVYPICSQTYIKEEYKEFVCNHDDNILERYLADSEISPADYWNTIIDLVAKAKVYPVLHGSAMFNIGINELLDAISSFILPPESVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDIVRINDSEKFIKIKNLKTIYQGREINVDEVGANDIAIVEDMEDFRIGDYLGTKPCLIQGLSHQHPALKSSVRPDRSEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTIYKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPMLYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKGLGVFMVKPCGYQITKGDYSDNIRMNEKDKLLFMFQKSMSSK	97.56	gnl|BL_ORD_ID|1133|hsp_num:0	1183
NODE_2371_length_12012_cov_11.757_13 # 11908 # 12012 # -1 # ID=2371_13;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.467	NODE_2371_length_12012_cov_11.757_13 	11908	12012	-	Loose	2000	20.0162	Staphylococcus mupA conferring resistance to mupirocin	29.03	3000521	protein homolog model	n/a	n/a	mupirocin	antibiotic target alteration	antibiotic resistant isoleucyl-tRNA synthetase (ileS)	GCCGCACCGTTCTTGCCGCAGCTGGAGAAAAACCTGCACTGGCTGGATGCTGAATTTGCAAAACTGACAGAATATCAGCAAAAGCGGAATAACGCATCAAAATAA	AAPFLPQLEKNLHWLDAEFAKLTEYQQKRNNASK	MTKKYLNTQNEISAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKDLVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFNYEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQTALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSKIRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFVTNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEIIKLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPSHIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDEDIELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPADFIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELINKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNNEITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIGDSRGRFWEQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFINQALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELNIKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSLSSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKKKNLPINQRIDIYIGVTGELLESIKTNKNMFKENFVIKNIHLNVIDEYENTIHFNNKEIKISLLY	3.32	gnl|BL_ORD_ID|2146|hsp_num:0	2270
NODE_3669_length_7663_cov_2.86751_5 # 4923 # 5180 # 1 # ID=3669_5;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.519	NODE_3669_length_7663_cov_2.86751_5 	4923	5180	+	Strict	1000	21.1718	efpA	100.0	3003955	protein homolog model	n/a	n/a	rifamycin antibiotic; isoniazid	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAAAGCCCTGCTGCTGCTGTTGATTCGCTTTTATCGGAGGGTGCTTTCCCCTTTAAAAAAGCCATGCTGCCGCTATTATCCGACTTGGAGTGCTTATGCGTTGCAGGCGGTCAAACGGTTTGGGGCATGGCATGGAACGGGTCTGGCAGTTCGCCGGATTCTGCGGTGTAATCCATGGAGTCCCGGCGGATTTGATGCTGTACCCCTGACGCTGCCGCAAAAGCGGTATCGCTGGACGAAAATTAAATTGAAATAA	MKALLLLLIRFYRRVLSPLKKPCCRYYPTWSAYALQAVKRFGAWHGTGLAVRRILRCNPWSPGGFDAVPLTLPQKRYRWTKIKLK	MTALNDTERAVRNWTAGRPHRPAPMRPPRSEETASERPSRYYPTWLPSRSFIAAVIAIGGMQLLATMDSTVAIVALPKIQNELSLSDAGRSWVITAYVLTFGGLMLLGGRLGDTIGRKRTFIVGVALFTISSVLCAVAWDEATLVIARLSQGVGSAIASPTGLALVATTFPKGPARNAATAVFAAMTAIGSVMGLVVGGALTEVSWRWAFLVNVPIGLVMIYLARTALRETNKERMKLDATGAILATLACTAAVFAFSIGPEKGWMSGITIGSGLVALAAAVAFVIVERTAENPVVPFHLFRDRNRLVTFSAILLAGGVMFSLTVCIGLYVQDILGYSALRAGVGFIPFVIAMGIGLGVSSQLVSRFSPRVLTIGGGYLLFGAMLYGSFFMHRGVPYFPNLVMPIVVGGIGIGMAVVPLTLSAIAGVGFDQIGPVSAIALMLQSLGGPLVLAVIQAVITSRTLYLGGTTGPVKFMNDVQLAALDHAYTYGLLWVAGAAIIVGGMALFIGYTPQQVAHAQEVKEAIDAGEL	16.04	gnl|BL_ORD_ID|2221|hsp_num:0	2427
NODE_3887_length_7130_cov_2.8711_6 # 4378 # 4629 # 1 # ID=3887_6;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.623	NODE_3887_length_7130_cov_2.8711_6 	4378	4629	+	Loose	710	22.7126	efrB	52.38	3003949	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; rifamycin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGCACATAAGAAGGGCGCGTCCAGCTCGCGCAACGGTCGCGATTCAAACGCGCAATACCTCGGTGTGAAGAAGTTCGGCGGCGAAGCCGTCGTGGCCGGCAACATCATCGTTCGTCAGCGTGGCACCAAGTTCCACCCGGGTGAGAACGTCGGCATGGGCAAGGACCACACCCTGTTCGCCCTCAAGGACGGCAGCGTGAAGTTCGGCGTGCGTCGTGACCGCAAGGTCGTCGACGTGATTGCCGCCTGA	MAHKKGASSSRNGRDSNAQYLGVKKFGGEAVVAGNIIVRQRGTKFHPGENVGMGKDHTLFALKDGSVKFGVRRDRKVVDVIAA	LDTCRIFRRNAKSPVNIAKHAKFIRRLKWLCSENMTGFSVLKLYVRKKKPLKGFKQVNHRFKWFGFKASFISGLMLPLVQMTAYGTYIGVAVLGSYYVVAGVIVVGQLQAFIQYIWQISQPMGNITQLSAALQSASASTMRIFEILDEPEEELNEQDVPLPEPILGSVEFENVSFSYDPEKPLIRNLNFKVDAGQMVAIVGPTGAGKTTLINLLMRFYDVTEGAIKIDGIDTKKMNRSDVRSVFGMVLQDAWLYKGTIADNIRFGKLDATDYEVVDAAKTANVDHFIRTMPDGYEMEINSEGDNVSLGQKQLLTIARAVISDPKILILDEATSSVDTRLEALIQKAMDRVMEGRTSFVIAHR	22.93	gnl|BL_ORD_ID|2217|hsp_num:0	2422
NODE_3926_length_7043_cov_2.09259_2 # 817 # 966 # -1 # ID=3926_2;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.427	NODE_3926_length_7043_cov_2.09259_2 	817	966	-	Loose	275	21.9422	AAC(6')-Ii	60.0	3002556	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGCGCGAAAAAGGTGTGACAAAAATCTATATCAATTCCAGAAAAGCGACACTTGGATTCTATGAAAAGCTCGGCTATACCGCAGATTTTTCACAGGTAAGCGGCTCCGGAGAGTTTGAATGTGTGATGACGGAGAAAGAACTTGCGTAA	MREKGVTKIYINSRKATLGFYEKLGYTADFSQVSGSGEFECVMTEKELA	MIISEFDRNNPVLKDQLSDLLRLTWPEEYGDSSAEEVEEMMNPERIAVAAVDQDELVGFIGAIPQYGITGWELHPLVVESSRRKNQIGTRLVNYLEKEVASRGGITIYLGTDDLDHGTTLSQTDLYVHTFDKVASIQNLREHPYEFYEKLGYKIVGVLPNANGWDKPDIWMAKTIIPRPDSQ	26.92	gnl|BL_ORD_ID|1006|hsp_num:0	1050
NODE_4703_length_5691_cov_5.8813_1 # 3 # 131 # 1 # ID=4703_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.512	NODE_4703_length_5691_cov_5.8813_1 	3	131	+	Loose	650	21.557	otrC	66.67	3002894	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	CATTACCCTTATGACCACAACATGACACTGGATGCCAATCTCCAGGGCGTGAATGAGCAACTGAACGACCTGGAAGAATACAGGGAGGAACAGCAGGAGGCCGAATATAGCGGTGGAATGCGACGATGA	HYPYDHNMTLDANLQGVNEQLNDLEEYREEQQEAEYSGGMRR	MTRKTISNGARNAVEVRGLVKHFGEVKAVDGVDLDVREGTVLGVLGPXGAAXXRGALPAHVXGPDAGRRPWRFXTWCANRRALRRTIGXHRPVRXGRRESFSGRENLYMIGRXLDLSRKDARARADELLERFSLTEAAGRAAAKYSGGMRRRLDLAASMIGRPAVLYLDEPTTGLDPRTRNEVWDEVRSMVRDGATVLLTTQYMEEAEQLAHELTVIDRGRVIADGKVDELKTKVGGRTLQIRPAHAAELDRMVGAIAQAGLDGIAGATADHEDGVVNVPIVSDEQLSAVVGMLGERGFTISGHQHPSAQLXEVFLAITGQKTSEAADGGPQDGPQDQQGVQDKQYEEVPA	11.97	gnl|BL_ORD_ID|1905|hsp_num:0	1991
NODE_4873_length_5464_cov_4.24034_9 # 5397 # 5462 # 1 # ID=4873_9;partial=01;start_type=TTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.439	NODE_4873_length_5464_cov_4.24034_9 	5397	5462	+	Strict	600	18.0902	clbB	100.0	3002815	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	TTGTACCCTGACAACGAGAGAGGTGGTGACGTGTCGAATGAAAAGAATCTCATTCCGTTCAATGAA	LYPDNERGGDVSNEKNLIPFNE	MKLTSKYETIRRILSECKQPEYRYAQIMDAIFKQNIGEYERMTILPKFLRDELNRILGPNVCSIAPVKELTSKQVSKVLFAIPGDEQVEAVRLTYERGWKSYCISTQCGCGFRCKFCATGTIGLKRNLTADEITDQLLYFRLNGHSLDSISFMGMGEALANPHIFEAMTILTDPYLFGLGHRRITISTIGLLPGIDKLTREFPQVNLTFSLHSPFDDQRSELMPINDRFPVRDVLIALDRHIRETGRKVYIAYILLRGVNDSTAHAEAVAELLRGRGAWEHLYHVNLIPFNSTEVTPDSYRQSDPSRIKAFVRILKSRGISVTVRTQFGSDINAACGQLYRSE	6.41	gnl|BL_ORD_ID|113|hsp_num:0	127
NODE_4917_length_5413_cov_3.37719_1 # 115 # 1023 # 1 # ID=4917_1;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.446	NODE_4917_length_5413_cov_3.37719_1	115	1023	+	Strict	500	502.671	aad(6)	84.42	3002628	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(6)	ATGAGGACCGAGAAGGAAATGATGGATTTGATGCTTGATATAGCACGGCAGGACAGCCGTATCAGGATCATGACATTAGAAGGGTCGCGTACCAATGTGAATATTCCTAAGGACGAATTCCAGGATTATGATGTCACATACTTCGTAACAGATGTGGAATCCTTTACTTTAAAGGATGAATGGCTTAAAAGCTTCGGGAATATTATAATGATGCAAAAACCAGAGGATATGGAGCTATTCCCGGCGGAAGAAAGCGGATACTCCTATATCATGTATTTTGACGATTATAATAAAATTGACCTTACCTTACTGCCGCTGGAAGAGTTGAAGGATTATCTGAACGGCGACAAGCTGATGCAGGTTATTCTGGACAAGGACGGGAGGATTGACCGGGATGTGGTTCCCACCGATATTGATTACCACGTAAGAAAGCCCAGCGCCCGGGAATACGACGACTGCTGTAATGAATTCTGGGATGTAACCCCCTATGTGGTGAAGGGGCTGTGCCGTAAGGAAATTTTGTTTGCCATTGACCATCTGAACGAGATTGTCCGTCATGAGCTGCTTAGAATGATATCGTGGAAGGTAGGCATCGAAACAGGGTTTCAATTGAGCGTTGGCAAGAACTATAAGTTTATTGACAGGTATATATCCGAGGATTTGTGGAAGAGGCTTTTGTCCACATACCGGATGGATTCTTGTGAGAACGTATGGGAAGCATTGCTCCTATGCCACCAATTGTTCAGGGAGGTATCCGGTGAGGTGGCGGAAAGGCTTCATTATGACTATCCGGAATATGATAAAAATATAACAAAGTATACCCGGGACATGCATAAAAAATACACCGGTGAAACCGGCTGCCTGGATAGCACATATGCCGCTGATATAGAAGAGAGGCGGGAACAGTGA	MRTEKEMMDLMLDIARQDSRIRIMTLEGSRTNVNIPKDEFQDYDVTYFVTDVESFTLKDEWLKSFGNIIMMQKPEDMELFPAEESGYSYIMYFDDYNKIDLTLLPLEELKDYLNGDKLMQVILDKDGRIDRDVVPTDIDYHVRKPSAREYDDCCNEFWDVTPYVVKGLCRKEILFAIDHLNEIVRHELLRMISWKVGIETGFQLSVGKNYKFIDRYISEDLWKRLLSTYRMDSCENVWEALLLCHQLFREVSGEVAERLHYDYPEYDKNITKYTRDMHKKYTGETGCLDSTYAADIEERREQ	EGSRANINIPKDEFQDYDITYFVSDIEPFISNDDWLNQFGNIIMMQKPEDMELFPPEEKGFSYLMLFDDYNKIDLTLLPLEELDNYLKGDKLIKVLIDKDCRIKRDIVPTDIDYHVRKPSAREYDDCCNEFWNVTPYVIKGLCRKEILFAIDHFNQIVRHELLRMISWKVGIETGFKLSVGKNYKFIERYISEDLWEKLLSTYRMDSYENIWEALFLCHQLFRAVSGEVAERLHYAYPEYDRNITKYTRDMYKKYTGKTGCLDSTYAADIEERREQ	109.42	gnl|BL_ORD_ID|1489|hsp_num:0	1562
NODE_4917_length_5413_cov_3.37719_2 # 1020 # 1562 # 1 # ID=4917_2;partial=00;start_type=GTG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.376	NODE_4917_length_5413_cov_3.37719_2	1020	1562	+	Strict	300	362.073	SAT-4	96.11	3002897	protein homolog model	n/a	n/a	nucleoside antibiotic	antibiotic inactivation	streptothricin acetyltransferase (SAT)	GTGATTACAGAAATGAAAGCAGGGCACCTGAAAGATATCGATAAACCCAGCGAACCATTTGAGGTGATAGGTAAGATTATACCGAGGTATGAAAACGAGAATTGGACCTTTACAGAATTGCTCTATGAAGCGCCATATTTAAAAAGCTACCAAGACGAAGAGGATAAAGAGGATGAGGAGGCAGATTGCCTTGAATATGTAGACAATACGGATAAGATAATATATCTTTACTACCAAGACGATAAATGCGTCGGAAAAGTTAAACTGCGAAAAAATTGGAACCGGTACGCTTATATAGAAGATATCGCCGTATGTAAGGATTTCAGGGGGCAAGGCATAGGCAGCGCGCTTATCAATAAATCTATAGAATGGGCAAAGCATAAAAACTTGCATGGACTAATGCTTGAAACCCAGGACAATAACCTTATAGCTTGTAAATTCTATCATAATTGTGGTTTCAAAATCGGCGCCATCGATACTATGTTATATGCTAACTTTGGAAATAACTTTGAAAAAGCAGTTTTTTGGTATTTAAGGTTTTAG	VITEMKAGHLKDIDKPSEPFEVIGKIIPRYENENWTFTELLYEAPYLKSYQDEEDKEDEEADCLEYVDNTDKIIYLYYQDDKCVGKVKLRKNWNRYAYIEDIAVCKDFRGQGIGSALINKSIEWAKHKNLHGLMLETQDNNLIACKFYHNCGFKIGAIDTMLYANFGNNFEKAVFWYLRF	MITEMKAEHLKDIDKPSEPFEVIGKIIPRYENENWTFTELLYEAPYLKSYQDEEDEEDEEADCLEYIDNTDKIIYLYYQDDKCVGKVKLRKNWNRYAYIEDIAVCKDFRGQGIGSALINISIEWAKHKNLHGLMLETQDNNLIACKFYHNCGFKIGSVDTMLYANFENNFEKAVFWYLRF	100.00	gnl|BL_ORD_ID|1544|hsp_num:0	1505
NODE_4917_length_5413_cov_3.37719_3 # 1656 # 2450 # 1 # ID=4917_3;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.449	NODE_4917_length_5413_cov_3.37719_3	1656	2450	+	Perfect	500	536.184	APH(3')-IIIa	100.0	3002647	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	ATGGCTAAAATGAGAATATCACCGGAATTGAAAAAACTGATCGAAAAATACCGCTGCGTAAAAGATACGGAAGGAATGTCTCCTGCTAAGGTATATAAGCTGGTGGGAGAAAATGAAAACCTATATTTAAAAATGACGGACAGCCGGTATAAAGGGACCACCTATGATGTGGAACGGGAAAAGGACATGATGCTATGGCTGGAAGGAAAGCTGCCTGTTCCAAAGGTCCTGCACTTTGAACGGCATGATGGCTGGAGCAATCTGCTCATGAGTGAGGCCGATGGCGTCCTTTGCTCGGAAGAGTATGAAGATGAACAAAGCCCTGAAAAGATTATCGAGCTGTATGCGGAGTGCATCAGGCTCTTTCACTCCATCGACATATCGGATTGTCCCTATACGAATAGCTTAGACAGCCGCTTAGCCGAATTGGATTACTTACTGAATAACGATCTGGCCGATGTGGATTGCGAAAACTGGGAAGAAGACACTCCATTTAAAGATCCGCGCGAGCTGTATGATTTTTTAAAGACGGAAAAGCCCGAAGAGGAACTTGTCTTTTCCCACGGCGACCTGGGAGACAGCAACATCTTTGTGAAAGATGGCAAAGTAAGTGGCTTTATTGATCTTGGGAGAAGCGGCAGGGCGGACAAGTGGTATGACATTGCCTTCTGCGTCCGGTCGATCAGGGAGGATATCGGGGAAGAACAGTATGTCGAGCTATTTTTTGACTTACTGGGGATCAAGCCTGATTGGGAGAAAATAAAATATTATATTTTACTGGATGAATTGTTTTAG	MAKMRISPELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRADKWYDIAFCVRSIREDIGEEQYVELFFDLLGIKPDWEKIKYYILLDELF	MAKMRISPELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRADKWYDIAFCVRSIREDIGEEQYVELFFDLLGIKPDWEKIKYYILLDELF	100.00	gnl|BL_ORD_ID|1273|hsp_num:0	1332
NODE_5059_length_5233_cov_2.10506_6 # 4159 # 4341 # 1 # ID=5059_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.552	NODE_5059_length_5233_cov_2.10506_6 	4159	4341	+	Loose	850	25.409	adeC	39.13	3003811	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTTCATCATTCGTGGATCCGTGTATTGGCCGTTCGCCATCATAATGTGCATCGGATGTATCATCGGCAGTGCCATCGCACCTCCCGTAACCCGGCATATTCCCGAAAACATCATGCGTGCCGCCGCCGTGCTCACCGGCATCATCCTAGCCGTCAAACTCGGCTGGAGCACCTACTTCTAG	MFIIRGSVYWPFAIIMCIGCIIGSAIAPPVTRHIPENIMRAAAVLTGIILAVKLGWSTYF	MSKSTIVSRGLILSTLSIALVACVNMQAPQPAITSHIPQNFSQNHSGKMIAEKSYKEFISDPKLLQVIEISLNNNRDLRTATLNIERVQQEYQITKNSQLPTIGVTGNAVRQVSPSINPNNPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQIGLISNITQVWLNYAFAQANLNLAEQTLKAQVDAYNLNKKRFDVGIDSEVPLKQAQISVETARNDVATYKTQIQQAKNLLDLLAGHPVPQNLLPDHAIQNITFEKNFAAGLPSDLLNHRPDLKAAEYELRVAGANIGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIGPNIDLPIFDWGTRKTNIKIAETDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATAATYKLSMARYKAGVDSYFTVLDAQRSAYAAQQGLLALEQIKLNNQIEIYKVLGGGISKV	12.90	gnl|BL_ORD_ID|316|hsp_num:0	337
NODE_5298_length_4934_cov_33.1691_1 # 68 # 1288 # 1 # ID=5298_1;partial=00;start_type=ATG;rbs_motif=AGGAG/GGAGG;rbs_spacer=11-12bp;gc_cont=0.564	NODE_5298_length_4934_cov_33.1691_1	68	1288	+	Strict	790	790.03	tet(40)	98.28	3000567	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTTTGCTAAAAATTCAAAGGCATATTCTGTCTACCTGCTGTTCCGATTTGTCTGTTCCCTGGCGGTTTCTATGTCCACAGTGCTTTCCATCGTGTACCACCTGGAGGTGGTGCAGCTGGATGCTTTCCAGCTTGTCCTGGTAGGGACGGTTCAGGAGACCTCCTGCTTTCTGTTCGAGATGCCCACCGGTGTGGTGGCGGATTTGTATAGCCGTCGGCGCTCGGTGCTGATTGGAATGTTCCTCTACGGCCTGGGCTTTCTGATGGAGGGTGCGCTACCGTGGTTCGCGCCGGTTCTGCTGGCCCAGGTTGTCTGGGGTTGCGGTGATACCTTCATCACCGGCGCTCTGGAGGCGTGGATTGCCTCGGAGGAAGAGGACAAACCCATAGACAAGGTGTTCCTGCGGGGCAGTCAAATGGGGCAAATCGGCGGCGTTCTGGGCGTGGTGCTGGGCACACTGCTGGGAAACATAAACCTGCAAATGCCTCTCATCTTGGGGGGCAGTTTGTGCTTGTTGTTGGGGCTGGTGATGGTTCGCATCATGCCAGAAACCAACTTCTCCCCTGCTATTGAGGAACGGCAGGGCTTGCTTAAAGACTTTGTCTGCCTGTTCAAGCTCAACCTGGGCTTTGTGAAAGGCGCACCTGTGTTGCTGGCGCTCTTAGCAATCACACTATGCGGGGGACTTGCCAGTGAAGGCTTTGACCGGCTCTCCACCGCTCATTTTCTGGATGACACGGTAATACCCGTTATCGGGCCGCTGAACAGCGTCACTTGGTTCGGTGTTATCAGTCTTATCGGCAACGGCTTAGGTATTCTGGCTTCTCAGTTGCTCATCGCCCGCATGGAGAAAAAAGGGACTGTCAGCCGAACCAGTGTGGTCATGTCCACCAGCGCCGGGTATATCCTGTTCCTGGTTCTCTTCGCGGTGGGGCGGAGCTTTTGGTTCATGTTGTTGGTGTTCCTGCTGGCGGGGCTTATGCGCACCATCAAGGAGCCTGTGCTGGCCGCCTGGATGAACGACCAAGTGGATGAGAAAATGCGCGCCACAGTCTTTTCCACCAGCGGACAGCTGGACTCTTTCGGGCAGATCATCGGCGGGCCTATTGTGGGGCTGGTAGCCCAGCAGGTGTCCATACCCTGGGGGCTGGTCTGTACCGCTTTCCTGCTGTTGCCCGCGCTGTTCTTAGTGCCGGTGGCGGGAAAGAAGCGGGATTGA	MFAKNSKAYSVYLLFRFVCSLAVSMSTVLSIVYHLEVVQLDAFQLVLVGTVQETSCFLFEMPTGVVADLYSRRRSVLIGMFLYGLGFLMEGALPWFAPVLLAQVVWGCGDTFITGALEAWIASEEEDKPIDKVFLRGSQMGQIGGVLGVVLGTLLGNINLQMPLILGGSLCLLLGLVMVRIMPETNFSPAIEERQGLLKDFVCLFKLNLGFVKGAPVLLALLAITLCGGLASEGFDRLSTAHFLDDTVIPVIGPLNSVTWFGVISLIGNGLGILASQLLIARMEKKGTVSRTSVVMSTSAGYILFLVLFAVGRSFWFMLLVFLLAGLMRTIKEPVLAAWMNDQVDEKMRATVFSTSGQLDSFGQIIGGPIVGLVAQQVSIPWGLVCTAFLLLPALFLVPVAGKKRD	MFAKNSKAYSVYLLFRFVCSLAVSMSTVLSIVYHLEVVQLDAFQLVLVGTVLETSCFLFEIPTGVVADLYSRRRSVLIGMFLYGLGFLMEGALPWFAPVLLAQVVWGCGDTFITGALEAWIASEEEDKPIDKVFLRGSQMGQIGGVLGVVLGTLLGNINLQMPVILGGSLCLLLGLVLVRIMPETNFSPAIEERQGLLKDFVCLFKLNLGFVKGAPVLLALLAITLCGGLASEGFDRLSTAHFLDDTVIPVIGPLNSVTWFGVISLIGSGLGILASQLLIARMEKKGTVSRTSVVMSTSAGYILCLVLFAVGRSFWFMLLVFLLAGLMRTIKEPVLAAWMNDHVDEKMRATVFSTSGQLDSFGQIIGGPIVGLVAQQVSIPWGLVCTAFLLLPALFLVPVAGKKRD	100.00	gnl|BL_ORD_ID|928|hsp_num:0	945
NODE_6727_length_3770_cov_3.25114_3 # 1279 # 2274 # -1 # ID=6727_3;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.554	NODE_6727_length_3770_cov_3.25114_3 	1279	2274	-	Loose	300	29.6462	vanXYG	27.63	3003069	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanXY	ATGCACGAAGAAAAGATTGCACTGGTCCGTCGGCAAATTGAAGCCTTGGCAGCAGCTGTGGCGTCACGCAATATCCGCCATGTGTGGGTTGTGGCTTGCGGTGGTTCGCTGGCTACCTTAGATCCTTTCCGATATATTTTGACTGCGGAAACGGATAAGGTTTCCGCTGCGGCGGTGAATGCGGCAGAGTTTGCCGCAGAGCCGCCCAAGGGACTGGGAGAGGATTGTCTGGTGGTTCTCAACTCTCAAAGCGGCACCACGGCAGAGACCGTCCGCGCGGCGCAACTGGCTAAGGAGCGCGGCGCTTTGACAGCTGCATATACTACGGCGCCTGAATCTCCTCTGGAGCAAGCTGTGGACTTCCCCATCTACTACTATGATGACCCGGTGAATCCCTATCCGCTGCTGCTATCCATCTTCCCGGAGGTCTATCAGACGGTGTTTGCTTTACTGGATGTGTGGGAAGGAACAAAGCGTTTGCCGATTATGGAAACGGCTATGGAGAATTTGGAGGAAGTGTGCGGGCGTGCGACGGCTAGTTTTAAGCCGGAAGCTCTGGAATTTGCCGCGAATCACCGCACGGAACCCATCATCTATACCGTTTCCGCCGGTTTAGATCGCTGCATTGCGTACATTCTCACCAACTGTTCCTTTATGGAGTCCGTATGGCGCCACTCATCTCCGCTCCACGCAGGCGAATTGTTCCATGGCGCCTGTGAAGCAATTGACAAAGAAACGGCAGTGGTTGCATTCCTGGGGATCGGGCCGTGGCGCAGTGTGGAGGAACGGGCGGTGAAGTTCCTTCAGCGGGTAACCGACAAGCTAACGGTGTTGGACGCCGCTGCCCTGGATTTGACGGGGATTCCGGCAGAGGTTCAGGATATCGTGGCCCCGCTGGTGCTGCATGCCATTGCTTCTGACTACTGTCTGAGGCTCTCTCAGCGGCTTGGACATCCCATGAGTTCCCGGCGCTATATGGGTATCATGAAATACTAA	MHEEKIALVRRQIEALAAAVASRNIRHVWVVACGGSLATLDPFRYILTAETDKVSAAAVNAAEFAAEPPKGLGEDCLVVLNSQSGTTAETVRAAQLAKERGALTAAYTTAPESPLEQAVDFPIYYYDDPVNPYPLLLSIFPEVYQTVFALLDVWEGTKRLPIMETAMENLEEVCGRATASFKPEALEFAANHRTEPIIYTVSAGLDRCIAYILTNCSFMESVWRHSSPLHAGELFHGACEAIDKETAVVAFLGIGPWRSVEERAVKFLQRVTDKLTVLDAAALDLTGIPAEVQDIVAPLVLHAIASDYCLRLSQRLGHPMSSRRYMGIMKY	MMKTIELEKEEIYCGNLLLVNKNYPLRDNNVKGLVPADIRFPNILMKRDVANVLQLIFEKISAGNSIVPVSGYRSLEEQTAIYDGSLKDNGEDFTRKYVALPNHSEHQTGLAIDLGLNKKDIDFIRPDFPYDGICDEFRRAAPDYGFTQRYARDKEEITGISHEPWHFRYVGYPHSKIMQENGFSLEEYTQFIKAYLEDNKYLFEQAHRAEIEIYYVPAKDDKTLIKIPENCVYQISGNNIDGFVVTIWRKTDD	130.31	gnl|BL_ORD_ID|237|hsp_num:0	253
NODE_7122_length_3524_cov_2.36927_3 # 1414 # 2298 # 1 # ID=7122_3;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.606	NODE_7122_length_3524_cov_2.36927_3 	1414	2298	+	Strict	500	24.2534	APH(6)-Ic	100.0	3002659	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(6)	ATGGATCTTATTTCATTCCTTCCCCGGGCAGTCATGCAGGGTATTCCCCTGCTCTATGGCAGCACCGGCGAGATCCTGACGGAGAAATCCGGCAACCTGAACTTAGGTATCCCCGGCATCATGTATGTGGGCGGCATCTGCGGCGTCATCGGTGCGTTCTTCTACGAGCAGTCCACCCCTGCGGCCTCTATGAACGGCCTTCTGGCCGTTGGAATCCCTATGCTGTGCTCCCTGCTGGGCTCTCTGCTGATGGGTCTGCTGTACTGCCTGCTGACGGTGACCCTCCGGGCCAACCAGAACGTGACCGGCCTTGCCATGACCACCTTCGGCGTGGGCATCGGCAACTTCTTCGGCGGCTCTCTCATCAAGCTGACGGGCAGCGAGGTCCCCTCCATCGCCCTTTCCACCACCAGCGCCTATTTCAGCAAATCCCTCCCCTTCGCCGCCAAATGCGGCTGGTTTGGTCAGATATTCCTGTCCTATGGATTCCTGGCGTATCTGGCTATTCTGCTGGCGCTGCTGGCCTCCTACTTCCTCAAGCACACCCGTCCCGGACTGCATCTCCGGGCCGTGGGTGAGAGCGCATCCACGGCGGACGCCGCCGGCATCAACGTCACTAAGTACAAGTATCTGGCTACCTGCGTTGGCAGTATGATCGCGGGTCTCGGCGGACTGTACTATGTGATGGACTACGCCTCCGGCGTCTGGTCCAACAATGCCTTCGGCGACCGCGGCTGGCTGGCCATCGCACTGGTGATCTTCACCATCTGGCGGCCCAACGTCAGCGTGCTGGCTTCCATCCTGTTCGGCGGGNNNNNNNNNNCATTCCCACCGGCACCAATCTGGCCATCAAGGAGCTTTACAAGATGCTCCCCTATGTGGTAA	MDLISFLPRAVMQGIPLLYGSTGEILTEKSGNLNLGIPGIMYVGGICGVIGAFFYEQSTPAASMNGLLAVGIPMLCSLLGSLLMGLLYCLLTVTLRANQNVTGLAMTTFGVGIGNFFGGSLIKLTGSEVPSIALSTTSAYFSKSLPFAAKCGWFGQIFLSYGFLAYLAILLALLASYFLKHTRPGLHLRAVGESASTADAAGINVTKYKYLATCVGSMIAGLGGLYYVMDYASGVWSNNAFGDRGWLAIALVIFTIWRPNVSVLASILFGGXXXXFPPAPIWPSRSFTRCSPMW	MERWRLLRDGELLTTHSSWILPVRQGDMPAMLKVARIPDEEAGYRLLTWWDGQGAARVFASAAGALLMERASGAGDLAQIAWSGQDDEACRILCDTAARLHAPRSGPPPDLHPLQEWFQPLFRLAAEHAALAPAASVARQLLAAPREVCPLHGDLHHENVLDFGDRGWLAIDPHGLLGERTFDYANIFTNPDLSDPGRPLAILPGRLEARLSIVVATTGFEPERLLRWIIAWTGLSAAWFIGDGDGEGEGAAIDLAVNAMARRLLD	110.53	gnl|BL_ORD_ID|856|hsp_num:0	892
NODE_8454_length_2897_cov_16.7699_2 # 1663 # 2829 # 1 # ID=8454_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.375	NODE_8454_length_2897_cov_16.7699_2	1663	2829	+	Strict	750	798.119	tetX	99.23	3000205	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGACAATGCGAATAGATACAGACAAACAAATGAATTTACTTAGTGATAAGAACGTTGCAATAATTGGTGGTGGACCCGTTGGACTGACTATGGCAAAATTATTACAGCAAAACGGCATAGACGTTTCAGTTTACGAAAGAGACAACGACCGAGAGGCAAGAATTTTTGGTGGAACCCTTGACCTACACAAAGGTTCAGGTCAGGAAGCAATGAAAAAAGCGGGATTGTTACAAACTTATTATGACTTAGCCTTACCAATGGGTGTAAATATTGCTGATGAAAAAGGCAATATTTTATCCACAAAAAATGTAAAGCCCGAAAATCGATTTGACAATCCTGAAATAAACAGAAATGACTTAAGGGCTATCTTGTTGAATAGTTTAGAAAACGACACGGTTATTTGGGATAGAAAACTTGTTATGCTTGAACCTGGTAAGAAGAAGTGGACACTAACTTTTGAGAATAAACCGAGTGAAACAGCAGATTTGGTTATTCTTGCCAATGGCGGGATGTCCAAGGTAAGAAAATTTGTTACCGACACGGAAGTTGAAGAAACAGGTACTTTCAATATACAAGCCGATATTCATCAACCAGAGATAAACTGTCCTGGATTTTTTCAGCTATGCAATGGAAACCGGCTAATGGCATCTCACCAAGGTAATTTATTATTTGCTAACCCCAATAATAATGGTGCATTGCATTTTGGAATAAGTTTTAAAACACCTGATGAATGGAAAAACCAAACGCAGGTAGATTTTCAAAACAGAAATAGTGTCGTTGATTTTCTTCTGAAAGAATTTTCCGATTGGGACGAACGCTACAAAGAATTGATTCATACGACGTTGTCATTTGTAGGATTGGCTACACGGATATTTCCTTTAGAAAAGCCTTGGAAAAGCAAGCGCCCATTACCCATAACAATGATTGGGGATGCCGCACATTTGATGCCGCCTTTTGCAGGGCAGGGAGTAAATAGTGGGTTGGTGGATGCCTTGATATTGTCTGATAATCTAGCCGATGGAAAATTTAATAGCATTGAAGAGGCTGTTAAAAATTATGAACAGCAAATGTTTATCTATGGCAAAGAAGCACAAGAAGAATCAACTCAAAACGAAGTTGAAATGTTTAAACCCGACTTTACGTTTCAGCAATTGTTAAATGTATAA	MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFIYGKEAQEESTQNEVEMFKPDFTFQQLLNV	MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADKKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFMYGKEAQEESTQNEIEMFKPDFTFQQLLNV	100.00	gnl|BL_ORD_ID|734|hsp_num:0	776
NODE_8542_length_2896_cov_2.07646_4 # 2667 # 2879 # 1 # ID=8542_4;partial=00;start_type=GTG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.469	NODE_8542_length_2896_cov_2.07646_4 	2667	2879	+	Loose	275	22.3274	tet34	34.78	3002870	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target alteration; antibiotic inactivation	tetracycline inactivation enzyme	GTGGTGAAAGAGATTCCGGATGGCGTGGAGGTTACAACGCGCGAAAAGAATGGAATCCGGTATGTGTTCGTACAGAACTTTAATCGGAATGCCGTGGAAATCAAACTTCCGGTCGAACAGTATCCGGTGTGGAACGGACAGTATGATGGAACAATCGGAAGCTGGGAAACAGTGGTGCTGAAAGAAAACAGTCCGAATTTCCGGGAAAAATAA	VVKEIPDGVEVTTREKNGIRYVFVQNFNRNAVEIKLPVEQYPVWNGQYDGTIGSWETVVLKENSPNFREK	MSKKFIITWDAMQNYCRQLAEKQMPAEQWKGIWAVSRGGLVPGAILARELGIRHVDTICISSYDHDHQRDMTVLKAPEGDGEGYLIVEDLVDSGDTARKLREMYPKAKLIAVCAKPSGATLLDDYVVDIAQDTWIEQPWDTTVQFVEPINRKQK	45.45	gnl|BL_ORD_ID|1246|hsp_num:0	1302
NODE_8555_length_2865_cov_2.48897_4 # 2400 # 2864 # 1 # ID=8555_4;partial=01;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.574	NODE_8555_length_2865_cov_2.48897_4 	2400	2864	+	Strict	450	23.0978	Chryseobacterium meningosepticum BlaB	100.0	3000579	protein homolog model	n/a	n/a	carbapenem; penam	antibiotic inactivation	BlaB beta-lactamase	ATGGCTGTTAAAGTTGCTATCAATGGTTTTGGCCGTATCGGCCGTCTGGCTTTCCGTCAGATGTTCGAGGCTGACGGTTACGAAGTCGTCGCCATCAACGATCTGACCAGCCCCGCTATGCTGGCTCACCTGCTGAAGTACGACACCGCACAGGGCTCTTTCCTGGGCAAGATCGGCGAGAACAAGCACACCGTTGAGGCTGGCGAGGATTACATCGTCGTCGACGGCAAGAAGATCACCATCTACGCAATTAAGGATGCTAAGGATTGCCCCTGGGGCGAGCTGGGCATCGACGTCGTTCTGGAGTGCACCGGCTTCTACACCAGCAAGGCTAAGGCTGAGGCTCACATCCAGGCTGGCGCCCGCAAGGTCGTTATCTCTGCTCCCGCCGGCAACGACCTGAAGACCATCGTCTACTCCGTCAACGAGAAGACCCTGACCGCTGAGGATCAGGTCATCTCCGCT	MAVKVAINGFGRIGRLAFRQMFEADGYEVVAINDLTSPAMLAHLLKYDTAQGSFLGKIGENKHTVEAGEDYIVVDGKKITIYAIKDAKDCPWGELGIDVVLECTGFYTSKAKAEAHIQAGARKVVISAPAGNDLKTIVYSVNEKTLTAEDQVISA	MKKIKISLILALGLTSLKAFGQENPDVKIEKLKDNLYVYTTYNTFNGTKYAANAVYLVTDKGVVVIDCPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKIGAKTYSTKMTDSILAKENKPRAQYTFDNNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLVGGCIIKSADSKDLGYIGEAYVNDWTQSVHNIQQKFSGAQYVVAGHDDWKDQRSIQHTLDLINEYQQKQKASN	62.50	gnl|BL_ORD_ID|223|hsp_num:0	237
NODE_9444_length_2566_cov_2.4325_1 # 3 # 95 # 1 # ID=9444_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.419	NODE_9444_length_2566_cov_2.4325_1 	3	95	+	Loose	1650	20.7866	Brucella suis mprF	40.91	3003772	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	ACCGTAACAGATAATGCTGACGAAAGATTCCCAGAGGTGGGCGTTGTGTCCTATATGCCGGAAGTCTATAAAATATCTATGGTTAGAATGTAG	TVTDNADERFPEVGVVSYMPEVYKISMVRM	MLWWDDISMSLIDDEIPSSQPQVSGRHFGWLKQYQHFLFPIAGIAIALLAIYVLENLLRHTSRTETLAALHNISWTTLALAVFFTALSYAAVALYDVVAVDTIAPNQIPRRIAAVAGAAGYAISNALGFSLLTGGALRYRIYAAEGISLADIGKIVGTSWFAIWFALIIMVGAALLIDPQDVPFLSAIDIRIDIVAGILILGGIGWLIYWLSHGERNVSIGSFSLRLPNSKGALTQIFAGVVDVGAAAATLYVLLPEGAVPSFAVFALVYVIAIVLGIASHAPGGLGAFEATIIAGLGLGGKPDAIAGLLAYRLIYTVLPLVVATAGILIWEVMRRRHMLDKQARFAKRLVEPLVPGLSASIIFLGGIILLISGATPDMRYRVKLLSDIVPEFLVEMSHLAASLVGVALLIVARGLSKRLERAWVAAMVLLLCGAVFSIAKGLDWEEASILCLFALSLWGFRDSFYRRPIAGPFELSWNWIATVGTTVLVSTWLGFFVYRHIEYSSDLWWDFAWNGNAPRFLRATVLVFAVVAAVGLHSIINRHGQRRRKVDHSIPDAVPALVARCPHTDAALAMLGDKQFLLAPDDSAFIMYAQSGGSLIALGEPIGDAEAGKELAWSFHSLADRLALRTVFYGVGPQSLPLFLDMGLIALKLGEVARVDLTDFSLEGPRRQPFRYADRKVDKDGLTFEIIPAADVPPLIPRLRAISDAWLDHKSGSEKGFSLGYFNDEYLKRFDIAVLKKDGEIVAFANIWRGADKYEITVDLMRYMPNVHKLLMDALFAKLLTFSKQEGYKWFNLGAAPLSGLSGSRLASRWNRFGSFIYRRGADLYHFDGLKAFKEKFDPVWTPHYMVCPGGLETPRALLDATTLINGSPLEFIRK	3.41	gnl|BL_ORD_ID|2130|hsp_num:0	2281
NODE_10892_length_2175_cov_3.79434_2 # 1986 # 2174 # 1 # ID=10892_2;partial=01;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.508	NODE_10892_length_2175_cov_3.79434_2 	1986	2174	+	Strict	1200	124.405	tetW	96.83	3000194	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAACATTATCAATATCGGGATTCTTGCCCATGTAGACGCTGGAAAGACGACCTTGACGGAGAGTCTGCTATATGCCAGTGGAGCCATTTCAGAACCAGGGAGCGTCGAAAAAGGGACAACGAGGACGGACACCTTGTTTTTGGAGCGGCAGCGTGGGATTACCATTCAAGCGGCAGTCACTTCCTTC	MNIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTLFLERQRGITIQAAVTSF	MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAVTSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQPIGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALGGREKLKITEMRIPSKGEIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRERLLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIYMERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDGIRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYLSFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGRSVCLTELKGYQAAVGQPVIQPRRPNSRLDKVRHMFQKVM	9.86	gnl|BL_ORD_ID|364|hsp_num:0	389
NODE_10896_length_2174_cov_1.73572_4 # 1369 # 1611 # -1 # ID=10896_4;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.519	NODE_10896_length_2174_cov_1.73572_4 	1369	1611	-	Loose	500	23.0978	OXA-257	50.0	3001694	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAAAAGAATTGGTCTTGTAGTTGCATATGACGGCACCAACTACTGTGGCTGGCAGACACAGCCAAACGGGATTACCGTGCAGGGGGTTTTAAATGAAACACTGTCCGAGCTTCTTGGCGAGAAGATAGAAACGATCGGTGCAAGCCGTACAGACGNNNNNNNNNNNNNNNNNNNATGGGAAATGTGGCAGTATTTGACACCAACACACGCATTCCCGGAGAAAAGATTTCCTATGCACTGA	MKRIGLVVAYDGTNYCGWQTQPNGITVQGVLNETLSELLGEKIETIGASRTDXXXXXXXWEMWQYLTPTHAFPEKRFPMH	MKFKMKGLFYVILSSLAFSGCVYDSKLQRPVISERETEIPLLFNQAQTQAVFVTYDGIHLKSYGNDLSRAKTEYIPASTFKMLNALIGLQNAKATNTEVFHWNGEKRAFSAWEKDMTLAEAMQASAVPVYQELARRIGLELMREEVKRVGFGNAEIGQQVDNFWLVGPLKISPEQEVQFAYQLAMKQLPFDRNVQQQVKDMLYIERRGDSKLYAKSGWGMDVEPQVGWYTGWVEQPNGKVTAFALNMKMQAGDDLAERKQLTLSILDKLGLFFYLR	28.99	gnl|BL_ORD_ID|1329|hsp_num:0	1394
NODE_10902_length_2173_cov_71.483_1 # 68 # 1987 # -1 # ID=10902_1;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.531	NODE_10902_length_2173_cov_71.483_1	68	1987	-	Strict	1200	1312.36	tetW	99.84	3000194	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAAAATAATCAATATTGGAATTCTTGCCCATGTAGACGCTGGAAAGACGACCTTGACGGAGAGCCTGCTATATGCCAGCGGAGCCATTTCAGAACCGGGGAGCGTCGAAAAAGGGACAACGAGGACGGACACCATGTTTTTGGAGCGGCAGCGTGGGATTACCATTCAAGCGGCAGTCACTTCCTTCCAGTGGCACAGATGTAAAGTTAACATTGTGGATACGCCCGGCCACATGGATTTTTTGGCGGAGGTGTACCGCTCTTTGGCTGTTTTAGATGGGGCCATCTTGGTGATCTCCGCTAAAGATGGCGTGCAGGCCCAGACCCGTATTCTGTTCCATGCCCTGCGGAAAATGAACATTCCCACCGTTATCTTTATCAACAAGATCGACCAGGCTGGCGTTGATTTGCAGAGCGTGGTTCAGTCTGTTCGGGATAAGCTCTCCGCCGATATTATCATCAAGCAGACGGTGTCGCTGTCCCCGGAAATAGTCCTGGAGGAAAATACCGACATAGAAGCATGGGATGCGGTCATCGAAAATAACGATGAATTATTGGAAAAGTATATCGCAGGAGAACCAATCAGCCGGGAAAAACTTGCGCGGGAGGAACAGCAGCGGGTTCAAGACGCCTCCCTGTTCCCAGTCTATCATGGCAGCGCCAAAAATGGCCTTGGCATTCAACCGTTGATGGATGCGGTGACAGGGCTGTTCCAACCGATTGGGGAACAGGGGGGCGCCGCCCTATGCGGCAGCGTTTTCAAGGTTGAGTACACCGATTGCGGCCAGCGGCGTGTCTATCTACGGTTATACAGCGGAACGCTGCGCCTGCGGGATACGGTGGCCCTGGCCGGGAGAGAAAAGCTGAAAATCACAGAGATGCGTATTCCATCCAAAGGGGAAATTGTTCGGACAGACACCGCTTATCAGGGTGAAATTGTTATCCTTCCCAGCGACAGCGTGAGGTTAAACGATGTATTAGGGGACCAAACCCGGCTCCCTCGTAAAAGGTGGCGCGAGGACCCCCTCCCCATGCTGCGGACGACGATTGCGCCGAAAACGGCAGCGCAAAGAGAACGGCTGCTGGACGCTCTTACGCAACTTGCGGATACTGACCCGCTTTTGCGTTGCGAAGTGGATTCCATCACCCATGAGATCATTCTTTCTTTTTTGGGCCGGGTGCAGTTGGAGGTTGTTTCCGCTTTGCTGTCGGAAAAATACAAGCTTGAAACAGTGGTAAAGGAACCCTCCGTCATTTATATGGAGCGGCCGCTCAAAGCAGCCAGCCACACCATCCATATCGAGGTGCCGCCCAACCCGTTTTGGGCATCCATAGGACTGTCTGTTACACCACTCTCGCTTGGCTCCGGTGTACAATACGAGAGCCGGGTTTCGCTGGGATACTTGAACCAGAGTTTTCAAAACGCTGTCAGGGATGGTATCCGTTACGGGCTGGAGCAGGGCTTGTTCGGCTGGAACGTAACGGACTGTAAGATTTGCTTTGAATACGGGCTTTATTACAGTCCGGTCAGCACGCCGGCGGACTTCCGCTCATTGGCCCCGATTGTATTGGAACAGGCATTGAAGGAATCGGGGACGCAGCTGCTGGAACCTTATCTCTCCTTCATCCTCTATGCGCCCCAGGAATACCTTTCCAGGGCTTATCATGATGCACCGAAATACTGTGCCACCATCGAAACGGCCCAGGTAAAAAAGGATGAAGTTGTCTTTACTGGCGAGATTCCCGCCCGCTGTATACAGGCATACCGTACTGATCTGGCCTTTTACACCAACGGGCGGAGCGTATGCCTTACAGAGCTGAAAGGATATCAGGCCGCTGTCGGTCAGCCGGTCATCCAGCCCCGCCGTCCAAACAGCCGCCTGGACAAGGTGCGCCATATGTTTCAGAAGGTAATGTAA	MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAVTSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQPIGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKGEIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRERLLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIYMERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDGIRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYLSFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGRSVCLTELKGYQAAVGQPVIQPRRPNSRLDKVRHMFQKVM	MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAVTSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQPIGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALGGREKLKITEMRIPSKGEIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRERLLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIYMERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDGIRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYLSFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGRSVCLTELKGYQAAVGQPVIQPRRPNSRLDKVRHMFQKVM	100.00	gnl|BL_ORD_ID|364|hsp_num:0	389
NODE_11464_length_2045_cov_1.65528_2 # 842 # 1264 # 1 # ID=11464_2;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.487	NODE_11464_length_2045_cov_1.65528_2 	842	1264	+	Loose	500	25.0238	rmtC	30.16	3000861	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	ATGGAAAAGGTCAAAGTGACAATGACCGTACTTTTTGAGGAGCCTTTCTGGATCGGTATTTACGAGCGGGAGGATGGAGAAAGCTATCAGGCGACAAAGATCCTTTTTGGTGCAGAGCCAAAGGGGATGGAAGTGCAGGAGTATTTGCTGAAAAATGTGTATCGGCTTTCTTTTGGTACCGGAAAAACAAGCCGGCTTTCTGACAGGCAGACCCGCAAGAACCCTAAACGGATGCAGCGGGAAATCCGTAAGCAGACAAGAGAAGGGGGAACAGGAACCCGCGCCCAGCAAGCCATACAGGCACAGCGGGAAGAGCGAAAAATCCAAAAGCGCATCATCCGAAAGGAAGATAAGCTGGCGGAGGAAAAAGAACGGTTTTTGCAGAAACAACAGAAGAAACGCGAAAAACATCGTGGACACTAA	MEKVKVTMTVLFEEPFWIGIYEREDGESYQATKILFGAEPKGMEVQEYLLKNVYRLSFGTGKTSRLSDRQTRKNPKRMQREIRKQTREGGTGTRAQQAIQAQREERKIQKRIIRKEDKLAEEKERFLQKQQKKREKHRGH	MKTNDNYIEEVTAKVLTSGKYSTLYPPTVRRVTERLFDRYPPKQLEKEVRKKLHQAYGAYIGGIDGKRLEKKIEKIIHEIPNPTTDEATRTEWEKEICLKILNLHTSTNERTVAYDELYQKIFEVTGVPTSITDAGCALNPFSFPFFTEAGMLGQYIGFDLDKGMIEAIEHSLRTLNAPEGIVVKQGDILSDPSGESDLLLMFKLYTLLDRQEEASGLKILQEWKYKNAVISFPIKTISGRDVGMEENYTVKFENDLVGSDLRIMQKLKLGNEMYFIVSRL	49.82	gnl|BL_ORD_ID|1469|hsp_num:0	1540
NODE_12514_length_1831_cov_1.72917_5 # 1691 # 1831 # 1 # ID=12514_5;partial=01;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.582	NODE_12514_length_1831_cov_1.72917_5 	1691	1831	+	Strict	2200	20.0162	Bifidobacterium ileS conferring resistance to mupirocin	100.0	3003730	protein homolog model	n/a	n/a	mupirocin	antibiotic target alteration	antibiotic resistant isoleucyl-tRNA synthetase (ileS)	ATGTATCGCGGCTTTATCAAGTGTTGGCGATGTGCCGAGGATAGCCGGGCGTGGAGCCGGGGGGCCTTGCATCGCGGGGTCATGTTGACCATTTTGCTCAAAGTGGCATGGAAGGATTGCTACTATCGCGGCGACGAGCTG	MYRGFIKCWRCAEDSRAWSRGALHRGVMLTILLKVAWKDCYYRGDEL	MSETTNSHVYPKANEGGETASVAPNPSFPNMEETVLKYWDKDDTFNKSVERNPSGDHSQNEFVFFDGPPFANGLPHYGHLLTGYAKDVIPRYQTMKGRKVNRVFGWDTHGLPAELEAQKELGIDSVDQIEKMGIDKFNDACRASVLKYTHEWQDYVHRQARWVDFEHGYKTLNIPYMESVMWAFKQLYEKGLAYQGYRVLPYCPKDQTPLSAHELRMDADVYQDRQDTTVSVAVKLRDEEDAYAVFWTTTPWTVPTNFAIVVGADIDYVEVRPTQGKYAGKKFYFGKPLLSKYEKELGEDYEVVRELKGSEMAGWRYWPVFPYFAGDKAESEGNVPGPEGYQIFTADYVDTVEGTGLVHQAPYGEDDMNTLNAHGIKSTDVLDAGCRFTAQCPDYEGMYVFDANKPILRNLRNGDGPLAEIPAEHRAILFQEKSYVHSYPHCWRCATPLIYKPVSSWFVSVTKIKPRLLELNQQINWIPENVKDGQFGKWLANARDWSISRNRFWGSPIPVWVSDDPKYPRVDVYGSLEELKADFGDYPRDKDGNVNMHRPWIDNLTRVNPDDPTGKSHMHRISDVLDCWFESGSMSFAQFHYPFENKEKFEQHFPADYIVEYIGQTRGWFYLLHVMATALFDRPAFKNVICHGIVLGSDGQKMSKHLRNYPDVNGVFDKYGSDAMRWFLMSSPILRGGNLIVTAEGIRDTVRQVMLPVWSSYYFFTLYANAANGGAGFDARQLRADEVAGLPEMDRYLLARTRRLVERVEKSLDEFAISDACDAASDFIDVLTNWYIRNTRDRFWKEDVNAFNTLYTVLEVFMRVLAPLAPMESESVWRGLTGGESVHLADWPYVADEKTGEATELGRVLVDDPALVDAMEKVREIVSGALSLRKAAQIRVRQPLAKLTVVVEDVDAVKAYDEILKSELNIKDIEFCTMEDAGSQGLKIVHELKVNARAAGPRLGKQVQFAIKASKTGAWHVDAATGAPVVETPNGEVALEAGEYELINRVEEENAAEADASVSAALPTGGFVILDTVLTADLEAEGYARDVIRAVQDARKAADLDIADRIALVLTVPSANVADVERFRDLIAHETLATSFAVKEGAELGVEVAKA	4.25	gnl|BL_ORD_ID|2128|hsp_num:0	2278
NODE_12577_length_1822_cov_2.03962_4 # 1739 # 1822 # 1 # ID=12577_4;partial=01;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.583	NODE_12577_length_1822_cov_2.03962_4 	1739	1822	+	Loose	700	22.7126	CMY-64	50.0	3002077	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CMY beta-lactamase	ATGAAAAAATCACGACTGCTTTCCGTTTTACTCTGCCTCGCCCTGCTCTCGGGGCTGCTGGCCACCTTTGCCTCCGCTGCGGAC	MKKSRLLSVLLCLALLSGLLATFASAAD	MMKKSLCCALLLTASLSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAIAVIYQGKPYYFTWGKADITNNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKAVHVSPGQLDAEAYGVKSSVIDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPVRVEAAWRILEKLQ	7.35	gnl|BL_ORD_ID|1516|hsp_num:0	1591
NODE_13050_length_1738_cov_1.64765_3 # 1644 # 1736 # 1 # ID=13050_3;partial=01;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.602	NODE_13050_length_1738_cov_1.64765_3 	1644	1736	+	Loose	2090	21.1718	smeB	58.33	3003052	protein homolog model	n/a	n/a	aminoglycoside antibiotic; cephalosporin; cephamycin; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGAGGACATGCACCTGATTCTCCGCTGGCACGGGGAGAAGGACCCCATCTCCCTGCGCCAGTACGCGCAGATTCCCAACCTGTACGGCATT	MEDMHLILRWHGEKDPISLRQYAQIPNLYGI	MVRFFIDRPIFAWVIAIAVSLLGLLAILILPVDRYPQIAPPTITIRATYTGASSQTVENAVTQVIEQSQQSLDHLMYMTSTSASDGSAQVNLVFATGTNPDTAQVQVQNQLQAAMATLPQAVQQNGLTITKSSGSIFEVLSFTSEDGSMDNFDVANFMEARIDDQISRVSGVGNIQPIGQEYAMRIWLDPEKMRQYALMPWDIETALQAQNTDVSAGELGGQPALKGQQLDATVTARSRLHTPEQFAQVVLKADANGSVVRLGDVAKIGLGPESYDSISTFNGKPSASLGIELNAGANAIAVSKAIDARLQQLQKYWPHGYTAHVAFTTTPFVTISLKEVVITLIEAIILVVLVMYLFLQNWRATLIPTIAVPVVLLGTFGVLAAFGYSINTLTMFALVLAIGLLVDDAIVVVENVERVMTFEGLAPKPATLKAMGQITGALVGIVLVLTAVFLPMAFFSGVTGVIYRQFSVTIAAAMILSVLVAMTITPALCGSILHQIPKGGHPHGDHGGEPSLLGKFFIWFNHRFERTSNGLRHRVDRFLGRRTLGVLFYLVLSVATGLLLWHLPGAFLPDEDQGMLNALVKLPAGSTLEQTRAVMDRLSAVAVKDDGVLSIQATAGFSVTGSGQNVGQAFIRLKDWDDRKDDADTIAARLTRAMASVPDAQVFITSPPAILGLGDAGGFTLELQDEGGAGHAAAVAARNTLLKEAAKDPKLVNVRYASLEDAPVYAVKVDDAKAQAMGVNPQDVNDTLNAALGGDFVNNFIYKGRIKKVFIQGTAEARMQPQDIERWSVRNQAGQMVPLSSLISTHWTSAPAAVQRYNGISAMEITGQPAPGVSSGEAMAEIARLADTLPEGFSHAWSDMAYQEQLSGNQAPMLYAISLLFVFLCLAALYESWAVPFAVMLAVPVGMFGAVLMMNLRGLNNDVYFQVGLLTTIGLAAKNGILIVEFARILEQQGKSTREAILQAVYLRLRPIVMTSLAFLMGVLPLVFATGAGSAARRSLGTGVAGGTVASMVLGMFFVPLFYLLVRRLFPGRAPADATVPETSP	2.96	gnl|BL_ORD_ID|1877|hsp_num:0	1960
NODE_13432_length_1680_cov_383.775_2 # 1099 # 1680 # 1 # ID=13432_2;partial=01;start_type=ATG;rbs_motif=TATAA;rbs_spacer=11bp;gc_cont=0.361	NODE_13432_length_1680_cov_383.775_2 	1099	1680	+	Strict	600	399.438	CfxA5	100.0	3003096	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CfxA beta-lactamase	ATGGAAAAAAACAGAAAAAAACAAATCGTAGTTTTGAGTATAGCTTTAGTTTGCATTTTCATCTTGGTATTTTCATTGTTCCATAAATCAGCGACAAAAGATAGCGCAAATCCTCCTTTAACAAATGTTTTGACTGATAGCATTTCTCAAATTGTCTCAGCTTGTCCTGGCGAAATTGGTGTGGCGGTTATTGTTAATAACAGAGATACGGTTAAGGTCAATAATAAGAGTGTTTATCCTATGATGAGTGTGTTTAAGGTTCATCAGGCATTAGCTCTTTGTAATGACTTTGACAATAAAGGAATTTCACTTGATACCTTAGTAAATATAAATAGGGATAAACTTGACCCAAAGACTTGGAGTCCTATGCTGAAAGATTATTCAGGGCCAGTCATATCATTGACAGTGAGAGATTTGCTGCGTTATACTCTTACTCAGAGTGACAACAATGCAAGCAACCTTATGTTTAAGGATATGGTTAATGTCGCTCAAACAGATAGTTTTATAGCCACACTCATTCCTCGTTCAAGTTTTCAGATAGCTTATACGGAAGAGGAAATGTCGGCTGACCATAACAAGGCT	MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIGVAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKA	MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIGVAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGCVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS	60.44	gnl|BL_ORD_ID|804|hsp_num:0	833
NODE_14647_length_1515_cov_1.8637_1 # 3 # 107 # 1 # ID=14647_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.457	NODE_14647_length_1515_cov_1.8637_1 	3	107	+	Loose	800	21.557	APH(4)-Ib	34.48	3002656	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(4)	GGCGGTCTGGCAAGAGTCATTGACCCCGACCGTAAGATCTTCGATGTTCTTGACCCCGTTCTGACATTGAAAGGTCTGAAGATTCTGTATCACAAAAACAAGTAA	GGLARVIDPDRKIFDVLDPVLTLKGLKILYHKNK	MLQTSKKKSGHDESWANADAHKWRGERKRDNRKIVLSGTTKLLFVAEEQFQLIPPPSYCVSLVPKLPSNVTQPLFEYCFAPRILFFYALKKMTQHTKLCKLSSLIWREMWAISSRLQWQCVCAARRITMRNGGWKFIEMLSCWSDMVHKHESVLISTLPSFINFLVGPFRSAGAEPGGMHRRVDPPRPLSPALIEAFDGVMQLSGAPSRGVTPTPRGPDALGRITDSRGGSEAGYRFNMCNRAVPSAALPIGEVLDIGEFSGKRTYLAAVHRAREQDLPETELPAVLQPCTGMAHAIAAADLSHTSGFAPFGPQGMGQETPWRDKRDCYFDPQVYYWLSQMGDTLRASVAQGFEKRMLWAEDCPEARHLRIHVKGSNAALPEPGPKTWAGDGSQAVWAGRLRPTQDSRYVVASIFPWRPW	8.10	gnl|BL_ORD_ID|1607|hsp_num:0	1681
NODE_14698_length_1510_cov_36.0515_2 # 878 # 1510 # 1 # ID=14698_2;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.254	NODE_14698_length_1510_cov_36.0515_2 	878	1510	+	Strict	500	424.861	OXA-347	100.0	3001777	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAAAAATATTTTATTTGTAGTTTTTATTTCAATGATATTTTTATTTGTTTGCTGTAACACAACAACGAATAAAAACATAATTGAAACAGAAATTTCTGATTTTGACAAAATTTTAGATAGTTTTCAAGTAAATGGTTCAATTCTAATTTATGATAACGACAAGAATACTTTTTACTCAAATGACTTTGATTGGGCTAAAAACGGAAAATTACCTGCATCAACATTCAAAATTCCAAATTCTATAATTGCTGTTGAATTAGGCATTATTGAAAATGATACAACTATTTTAAAATGGAATGGCGAGCAGAGAAAAATGGATATTTGGGAAAAAGATTTATCATTTAAAGATGCTTTTAGAATTTCCTGTGTTCCTTGCTATCAGGAAATTGCAAGGAAAATCGGAACAATTAAAATGAAAGAATATTTAGAAAAATTTGAGTATAAAAATATGATTTTTGACAGTTTAACGATTGACAATTTTTGGCTTGAAGGAAATTCAAAAATATCTCAAAAACAACAAATCGACTTTTTAAGGAAATTCTATTTTTCAAAATTTCCAATTTCTGATAGGACAATAAAGATTGTCAAAAATATTATGGAAATTGAGCGAACTGAAAATTACATTTTAAGC	MKNILFVVFISMIFLFVCCNTTTNKNIIETEISDFDKILDSFQVNGSILIYDNDKNTFYSNDFDWAKNGKLPASTFKIPNSIIAVELGIIENDTTILKWNGEQRKMDIWEKDLSFKDAFRISCVPCYQEIARKIGTIKMKEYLEKFEYKNMIFDSLTIDNFWLEGNSKISQKQQIDFLRKFYFSKFPISDRTIKIVKNIMEIERTENYILS	MKNILFVVFISMIFLFVCCNTTTNKNIIETEISDFDKILDSFQVNGSILIYDNDKNTFYSNDFDWAKNGKLPASTFKIPNSIIAVELGIIENDTTILKWNGEQRKMDIWEKDLSFKDAFRISCVPCYQEIARKIGTIKMKEYLEKFEYKNMIFDSLTIDNFWLEGNSKISQKQQIDFLRKFYFSKFPISDRTIKIVKNIMEIERTENYILSGKTGLSSIEEKYNGWFVGYVETKSNVYFFATNVIPTDGLNVDDFISSRINVTKNALKQMNIMK	77.01	gnl|BL_ORD_ID|651|hsp_num:0	690
NODE_15209_length_1448_cov_395.874_2 # 1010 # 1447 # -1 # ID=15209_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.356	NODE_15209_length_1448_cov_395.874_2 	1010	1447	-	Strict	600	302.753	CfxA2	100.0	3003002	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CfxA beta-lactamase	AGTTTTCAGATAGCTTATACGGAAGAGGAAATGTCGGCTGACCATAACAAGGCTTACTCTAACTATACATCTCCTCTTGGTGCTGCAATGTTGATGAATCGTTTGTTTACTGAAGGTCTTATCGATGATGAGAAACAAAGTTTCATTAAGAATACGTTAAAAGAATGCAAAACAGGTGTAGATAGGATAGCAGCTCCACTTCTTGATAAAGAAGGGGTTGTTATAGCGCATAAGACAGGTTCAGGTTATGTTAATGAAAATGGTGTTCTTGCAGCTCACAATGATGTTGCCTATATATGTCTGCCTAATAATATCAGTTATACCTTAGCGGTATTTGTTAAGGATTTCAAGGGAAATGAATCACAAGCGTCACAATATGTTGCGCATATATCAGCTGTAGTATATTCTTTATTAATGCAAACTTCAGTAAAATCTTAA	SFQIAYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGYVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS	MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIGVAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGYVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS	45.17	gnl|BL_ORD_ID|162|hsp_num:0	174
NODE_15453_length_1423_cov_21.875_1 # 2 # 1030 # -1 # ID=15453_1;partial=10;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.248	NODE_15453_length_1423_cov_21.875_1	2	1030	-	Strict	275	698.738	AAC(6')-Ie-APH(2'')-Ia	100.0	3002597	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(2''); AAC(6')	ATGAATATAGTTGAAAATGAAATATGTATAAGAACTTTAATAGATGATGATTTTCCTTTGATGTTAAAATGGTTAACTGATGAAAGAGTATTAGAATTTTATGGTGGTAGAGATAAAAAATATACATTAGAATCATTAAAAAAACATTATACAGAGCCTTGGGAAGATGAAGTTTTTAGAGTAATTATTGAATATAACAATGTTCCTATTGGATATGGACAAATATATAAAATGTATGATGAGTTATATACTGATTATCATTATCCAAAAACTGATGAGATAGTCTATGGTATGGATCAATTTATAGGAGAGCCAAATTATTGGAGTAAAGGAATTGGTACAAGATATATTAAATTGATTTTTGAATTTTTGAAAAAAGAAAGAAATGCTAATGCAGTTATTTTAGACCCTCATAAAAATAATCCAAGAGCAATAAGGGCATACCAAAAATCTGGTTTTAGAATTATTGAAGATTTGCCAGAACATGAATTACACGAGGGCAAAAAAGAAGATTGTTATTTAATGGAATATAGATATGATGATAATGCCACAAATGTTAAGGCAATGAAATATTTAATTGAGCATTACTTTGATAATTTCAAAGTAGATAGTATTGAAATAATCGGTAGTGGTTATGATAGTGTGGCATATTTAGTTAATAATGAATACATTTTTAAAACAAAATTTAGTACTAATAAGAAAAAAGGTTATGCAAAAGAAAAAGCAATATATAATTTTTTAAATACAAATTTAGAAACTAATGTAAAAATTCCTAATATTGAATATTCGTATATTAGTGATGAATTATCTATACTAGGTTATAAAGAAATTAAAGGAACTTTTTTAACACCAGAAATTTATTCTACTATGTCAGAAGAAGAACAAAATTTGTTAAAACGAGATATTGCCAGTTTTTTAAGACAAATGCACGGTTTAGATTATACAGATATTAGTGAATGTACTATTGATAATAAACAAAATGTATTAGAAGAGTATATATTGTTGCGTGAAACTATTTATAATGATTTA	MNIVENEICIRTLIDDDFPLMLKWLTDERVLEFYGGRDKKYTLESLKKHYTEPWEDEVFRVIIEYNNVPIGYGQIYKMYDELYTDYHYPKTDEIVYGMDQFIGEPNYWSKGIGTRYIKLIFEFLKKERNANAVILDPHKNNPRAIRAYQKSGFRIIEDLPEHELHEGKKEDCYLMEYRYDDNATNVKAMKYLIEHYFDNFKVDSIEIIGSGYDSVAYLVNNEYIFKTKFSTNKKKGYAKEKAIYNFLNTNLETNVKIPNIEYSYISDELSILGYKEIKGTFLTPEIYSTMSEEEQNLLKRDIASFLRQMHGLDYTDISECTIDNKQNVLEEYILLRETIYNDL	MNIVENEICIRTLIDDDFPLMLKWLTDERVLEFYGGRDKKYTLESLKKHYTEPWEDEVFRVIIEYNNVPIGYGQIYKMYDELYTDYHYPKTDEIVYGMDQFIGEPNYWSKGIGTRYIKLIFEFLKKERNANAVILDPHKNNPRAIRAYQKSGFRIIEDLPEHELHEGKKEDCYLMEYRYDDNATNVKAMKYLIEHYFDNFKVDSIEIIGSGYDSVAYLVNNEYIFKTKFSTNKKKGYAKEKAIYNFLNTNLETNVKIPNIEYSYISDELSILGYKEIKGTFLTPEIYSTMSEEEQNLLKRDIASFLRQMHGLDYTDISECTIDNKQNVLEEYILLRETIYNDLTDIEKDYIESFMERLNATTVFEGKKCLCHNDFSCNHLLLDGNNRLTGIIDFGDSGIIDEYCDFIYLLEDSEEEIGTNFGEDILRMYGNIDIEKAKEYQDIVEEYYPIETIVYGIKNIKQEFIENGRKEIYKRTYKD	71.61	gnl|BL_ORD_ID|1737|hsp_num:0	1814
NODE_15627_length_1402_cov_2.34892_2 # 577 # 1074 # -1 # ID=15627_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.319	NODE_15627_length_1402_cov_2.34892_2	577	1074	-	Perfect	300	340.117	dfrG	100.0	3002868	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGAAAGTTTCTTTGATTGCTGCGATGGATAAGAATAGAGTGATTGGCAAAGAGAATGACATTCCTTGGAGGATTCCCAAGGACTGGGAATATGTTAAAAATACTACAAAGGGACATCCGATAATATTAGGTAGGAAGAACCTTGAATCAATCGGAAGAGCCTTACCTGACAGAAGAAATATTATTCTGACGAGAGATAAGGGGTTTACCTTTAATGGTTGTGAAATTGTTCATTCAATAGAAGATGTTTTTGAGTTATGTAAAAACGAAGAAGAAATTTTTATTTTCGGAGGAGAACAGATTTATAATTTGTTTTTCCCTTATGTTGAGAAAATGTACATCACAAAAATACATCATGAATTCGAAGGAGATACTTTTTTTCCAGAAGTGAATTATGAGGAATGGAATGAGGTATTTGCCCAAAAAGGGATAAAGAATGATAAAAATCCGTATAACTACTATTTTCATGTATATGAAAGAAAAAACTTATTGAGTTAA	MKVSLIAAMDKNRVIGKENDIPWRIPKDWEYVKNTTKGHPIILGRKNLESIGRALPDRRNIILTRDKGFTFNGCEIVHSIEDVFELCKNEEEIFIFGGEQIYNLFFPYVEKMYITKIHHEFEGDTFFPEVNYEEWNEVFAQKGIKNDKNPYNYYFHVYERKNLLS	MKVSLIAAMDKNRVIGKENDIPWRIPKDWEYVKNTTKGHPIILGRKNLESIGRALPDRRNIILTRDKGFTFNGCEIVHSIEDVFELCKNEEEIFIFGGEQIYNLFFPYVEKMYITKIHHEFEGDTFFPEVNYEEWNEVFAQKGIKNDKNPYNYYFHVYERKNLLS	100.00	gnl|BL_ORD_ID|419|hsp_num:0	448
NODE_16435_length_1314_cov_2.73392_1 # 1 # 1170 # 1 # ID=16435_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.252	NODE_16435_length_1314_cov_2.73392_1	1	1170	+	Strict	275	657.522	AAC(6')-Ie-APH(2'')-Ia	82.29	3002597	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(2''); AAC(6')	TATGGAATGGATCAGTTTATAGGAGAACCTGAATATTGGAGTAAAGGCATTGGCTCAAAATATACAAAAATGATTTTTGAGTTTTTAAAAAAAGAAAGAAATGCTAATGCAGTTATTTTAGACCCTCATAAGAATAATCCAAGAGCAATTAGGTCATATCAGAAATCTGGATTTAGAATAATTGAAGATTTGCCAGAACACGAGTTGCACGAGGGTAAAAAAGAAGATTGCTATTTAATGGAATATAGGTATGATGATAATGTTACAAATGTTAAAGCAATGAAATACTTAATAGAACATTACTTTGAAGATTTTAAAGTTGAAAGTATTAAGGTAATTGGTAGTGGATATGATAGTGTAGCATATTTAGTAAATGGAGAATACATATTTAAAACAAAATTTAGTGCTAATAAGAAAAAAGGATATGAAAAAGAAAAAGCAATTTATGATTTCTTAAATCAAAGATTAAATACTAATATAAAAATACCAAATGTAAAATATTCATATTTTAGTGATGATATTTCTATATTAGGTTATAAAGAAATAAAAGGAACTTTTTTAACACCAGAAATATATTTTGCTTTATCAAAAGAAAAGCAAGAATTATTAAAGCAAGATATTGCTATGTTTTTAAGACAAATGCACGATTTAGATTATAGTGAAATAAGTTTGTATACGATAGACAATAAACAAAATGTTTTGGAAGAATATCAATTACTCAAAGACACAATATATGATAGTCTTACTGATATTGAAAAACAATATGTAGAAGACTTTATGCAAAGATTACATAGTACAACTATATTTGATGGTAAAAAATGCTTATGCCATAATGATTTTAGTTGTAATCATTTATTACTTGATGATGAAAATAGATTATGTGGTGTAATAGATTTTGGAGATTCTGGAATTATAGATGAATACTGTGATTTCATATATTTACTAGAAGATAGTGAAGAAGAAATTGGTGTATCTTTTGGAGAAGATATATTAAGATTATATGGTAATATTGATATTTCAAAAGCAAAGGAATATCAAGATGTTGTAGAACAATATTATCCAATAGAAACTATTGTATATGGTATTAAAAATAATAGACCTGATTTTATAGAAAAAGGTAGAAAAGAGATTTATATAAGAACTCGCAAAGATGAAAAATTAAGGAAGTGA	YGMDQFIGEPEYWSKGIGSKYTKMIFEFLKKERNANAVILDPHKNNPRAIRSYQKSGFRIIEDLPEHELHEGKKEDCYLMEYRYDDNVTNVKAMKYLIEHYFEDFKVESIKVIGSGYDSVAYLVNGEYIFKTKFSANKKKGYEKEKAIYDFLNQRLNTNIKIPNVKYSYFSDDISILGYKEIKGTFLTPEIYFALSKEKQELLKQDIAMFLRQMHDLDYSEISLYTIDNKQNVLEEYQLLKDTIYDSLTDIEKQYVEDFMQRLHSTTIFDGKKCLCHNDFSCNHLLLDDENRLCGVIDFGDSGIIDEYCDFIYLLEDSEEEIGVSFGEDILRLYGNIDISKAKEYQDVVEQYYPIETIVYGIKNNRPDFIEKGRKEIYIRTRKDEKLRK	MNIVENEICIRTLIDDDFPLMLKWLTDERVLEFYGGRDKKYTLESLKKHYTEPWEDEVFRVIIEYNNVPIGYGQIYKMYDELYTDYHYPKTDEIVYGMDQFIGEPNYWSKGIGTRYIKLIFEFLKKERNANAVILDPHKNNPRAIRAYQKSGFRIIEDLPEHELHEGKKEDCYLMEYRYDDNATNVKAMKYLIEHYFDNFKVDSIEIIGSGYDSVAYLVNNEYIFKTKFSTNKKKGYAKEKAIYNFLNTNLETNVKIPNIEYSYISDELSILGYKEIKGTFLTPEIYSTMSEEEQNLLKRDIASFLRQMHGLDYTDISECTIDNKQNVLEEYILLRETIYNDLTDIEKDYIESFMERLNATTVFEGKKCLCHNDFSCNHLLLDGNNRLTGIIDFGDSGIIDEYCDFIYLLEDSEEEIGTNFGEDILRMYGNIDIEKAKEYQDIVEEYYPIETIVYGIKNIKQEFIENGRKEIYKRTYKD	81.21	gnl|BL_ORD_ID|1737|hsp_num:0	1814
NODE_16855_length_1272_cov_1.4848_2 # 1181 # 1270 # 1 # ID=16855_2;partial=01;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.456	NODE_16855_length_1272_cov_1.4848_2 	1181	1270	+	Loose	275	19.2458	AAC(6')-Iz	40.0	3002570	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGATCACAGAAAACTTAAAAGATGTGGAAGCACGTGTATGTGCTGCATGCGAACGCTCCGGCAGAAAACGGGAGGATGTAACACTGATT	MITENLKDVEARVCAACERSGRKREDVTLI	MIASAPTIRQATPADAAAWAQLRLGLWPDADDPLEELTQSLADAEGAVFLACAADGETVGFAEVRLRHDYVNGTESSPVGFLEGWYVQPQWQGSGVGRALLAAVQAWTRDAGCRELASDSRVEDVQAHAAHRACGFEETERVVYFRMPLEPSA	19.61	gnl|BL_ORD_ID|1908|hsp_num:0	1995
NODE_18000_length_1173_cov_1.29785_3 # 1091 # 1171 # 1 # ID=18000_3;partial=01;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.667	NODE_18000_length_1173_cov_1.29785_3 	1091	1171	+	Loose	700	21.557	ACT-12	40.91	3001834	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	ACT beta-lactamase	ATGCTGCAAACCCTGTTGGATTCCTGCGCAGCGCTCGGTGTGCCGCTGACGGCGGCGCAGGCGGAGCAGCTGTGCGACTTC	MLQTLLDSCAALGVPLTAAQAEQLCDF	MMKKSLCCALLLSTSCAALAAPLSETQLAKVVERTVTPLMKAQSIPGMAVAVIYQGQPHYFTFGKADVAANTPVTAQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQWQGVRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQSWQPQWAPGTTRLYANASIGLFGALAVKPSGMRFEQAMTERVLKPLNLNHTWINVPKAEEQHYAWGYRDGKAVHVSPGMLDAEAYGVKTNVKDMASWVVANMAPDGVQDASLKQGMVLAQSRYWRTGSMYQGLGWEMLNWPVEAKTVVEGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKELGIVMLANKSYPNPARVEAAYRILSALQ	7.09	gnl|BL_ORD_ID|1436|hsp_num:0	1506
NODE_18187_length_1158_cov_1.55304_1 # 2 # 136 # 1 # ID=18187_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.385	NODE_18187_length_1158_cov_1.55304_1 	2	136	+	Loose	770	21.1718	tet(J)	42.11	3000177	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	AGAGCTGATTGTGATTTTGACGGTGACGGCTCAATCACAACAAAAGACCTTCTGTATGCAGGTATGTATTTTGGAAAGAAGACTCCTGTATTGGATAACCAAGGTCCCGACAAAGTCAAAATAAAAGCATATTAA	RADCDFDGDGSITTKDLLYAGMYFGKKTPVLDNQGPDKVKIKAY	MNKSIIIILLVTVLDAIGIGLIMPVLPTLLNEFVSENRLANHYGILLALYATMQVIFAPILGKLSDKYGRKPILLISLLGAALDYLLMACPTSLWMLYIGRIIAGITGATGAVCASAMTDVTHPHERTRYFGFLGGAFGVGLIIGPMLGGLLGEISAHTPFIFAAISHSLLFIFSLLCFQETQTTKISTEISALNQDTAPHSTTGFIKKSLFFWLIAYFIIQLIGQIPATIWVLFTQVRFAWHTTEVGLSLAFLGVLHIFFQAVLAGKLAQKWGERNTVIISMSIDAFGCLLLAWISHVWVMLPALICLAAGGMGQPALQGYLSKSVDHHVQGQLQGTLVSLTNITGIVGPLLFSFIYSYSVEYWDGLLWFIGAMLYSGLLVASYFKQKSPILKKFPS	11.06	gnl|BL_ORD_ID|1086|hsp_num:0	988
NODE_18282_length_1151_cov_9.57938_2 # 925 # 1149 # -1 # ID=18282_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.609	NODE_18282_length_1151_cov_9.57938_2 	925	1149	-	Strict	700	21.1718	tet(41)	100.0	3000569	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	AATACTACAAAGCGCATCCGGCGGGAGGCCAGATCGCCGGATGGCTTTCATGAGGGCGCCCGGGGCGGTGTGCGTATACCAGGCGGCGGGAACAACCAGACAGAGGAGGTGTCCGCCCCGTCTGACGAGGCCGCCAGACGCATGAAACGGGAGATTTTGTGTCTCCAGCAGCAGATGGCGTTCTTAAAAAAAGTCATGCGGCTGCACGGCAAGCCGGGAGAATAG	NTTKRIRREARSPDGFHEGARGGVRIPGGGNNQTEEVSAPSDEAARRMKREILCLQQQMAFLKKVMRLHGKPGE	MKKPMLVILLTVLLDAVGIGLIMPILPALLRSLGGLDAGSVHYGALLAAYALMQFLFSPILGALSDRFGRRPVLLISLAGAAADYLLMAFAPTLAWLYLGRLLAGITGANMAVATAYVTDITPVGQRARRFGLVGAVFGVGFIVGPLLGGSLGEWHLHAPFLAAAMMNALNLVMAFFLLPESRKSRPRAAEKIRLNPFSSLRRLHGKPGLLPLAGIYLVMALVSQAPATLWILYGQDRFGWSMMVAGLSLAGYGACHALSQAFAIGPLVARLGERKALLIGLAADAVGLALLSVATRGWAPFALLPFFAAGGMALPALQALMAHKVDDDHQGELQGTLASMGSLIGVAGPLVATALYAATRDVWPGLVWALAAALYLVVPPLLARSRARDAAP	18.83	gnl|BL_ORD_ID|1547|hsp_num:0	1584
NODE_18358_length_1145_cov_2.10642_2 # 1011 # 1145 # -1 # ID=18358_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.304	NODE_18358_length_1145_cov_2.10642_2 	1011	1145	-	Loose	200	21.557	ANT(3'')-IIc	33.33	3004091	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	ATTGCAGAAGCTGAAAAGATTGAGATAATTCCTACGCTGGTTTTATATCGAGATGGAAAGGCAATAGATTCTATTGTTGCACCTGAATCAAAAATAATGATAGAGAATTTTATTAATGAAGCATTGGAAAAATAA	IAEAEKIEIIPTLVLYRDGKAIDSIVAPESKIMIENFINEALEK	MSETLQLEQLTGYLQQLLGESLFAIYLYGSAVDGGLGPESDLDILVVVSQALTLPQRQQLAETLLQISHPIGAAQRALEVTIVRKDHILSGSYPLSYELQFGEWLRDELSQGDMLSEHADPDLSILLKKAQLHHRSLFGPSLTQWSVEIPDQQLWQAMADTYPSIVAHWDEDADERNQILALCRIYFSLVTNEIAPKDQAAQWVIAQLQPQHQPVLQRMVQEYKGEIEKQNWQQQHHALQPVVDFLSSKIDERFKQKKV	16.99	gnl|BL_ORD_ID|2304|hsp_num:0	2755
NODE_18775_length_1112_cov_1.83254_4 # 1029 # 1112 # 1 # ID=18775_4;partial=01;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.690	NODE_18775_length_1112_cov_1.83254_4 	1029	1112	+	Loose	450	20.7866	SPM-1	47.06	3003793	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	SPM beta-lactamase	ATGAGCTGGGGGGTATCCCACCTGCTGGCCCTGCTGACCGGCTTCTGCCTGGATCTCCTGCTGGGGGATCCCCACTGGGCGCCC	MSWGVSHLLALLTGFCLDLLLGDPHWAP	MNSPKSRALLGFMGAFCLLLVAGAPLSAKSSDHVDLPYNLTATKIDSDVFVVTDRDFYSSNVLVAKMLDGTVVIVSSPFENLGTQTLMDWVAKTMKPKKVVAINTHFHLDGTGGNEIYKKMGAETWSSDLTKQLRLEENKKDRIKAAEFYKNEDLKRRILSSHPVPADNVFDLKQGKVFSFSNELVEVSFPGPAHSPDNVVVYFPKKKLLFGGCMIKPKELGYLGDANVKAWPDSARRLKKFDAKIVIPGHGEWGGPEMVNKTIKVAEKAVGEMRL	10.14	gnl|BL_ORD_ID|2148|hsp_num:0	2298
NODE_18838_length_1108_cov_5.41975_3 # 1021 # 1107 # 1 # ID=18838_3;partial=01;start_type=ATG;rbs_motif=TAA;rbs_spacer=13bp;gc_cont=0.345	NODE_18838_length_1108_cov_5.41975_3 	1021	1107	+	Strict	700	20.7866	cmlv	100.0	3002700	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol phosphotransferase	ATGAATAAACAGATTTTATCAATTTTTGTTTTCTGTGCTTTTTCTTATTCTACACAAGCGCAAGAAGTGAAAGGAGGCATCAGCGAC	MNKQILSIFVFCAFSYSTQAQEVKGGISD	MPSPSAEPTTSTPTPDAGPAASPRMPLAVYILGLSAFALGTSEFMLSGLVPPIAEDMNVSIPRAGLLISAFAIGMVVGAPLLAVATLRLPRKTTLIALITVFGLRQMAGALAPNYAVLFASRVISALPCAGFWAVGAAVAIAMVPVGSRARALAVMIGGLSIANVLRVPAGAFLGEHLGWASAFWAVGLASAIALVGVVTRIPRIPLPETRPRPLKNEVAIYRDRQVLLSIAVTALAAGGVFCAFSYLAPLLTDVSGLDEAWVSGVLGLFGIGAVVGTTIGGRVADAHLFGVLLTGISASTVFLVALALFASNPAATIVLTFLLGVSAFYTAPALNARMFNVAGAAPTLAGATTTAAFNLGNTGGPWLGGTVIDANLGFASTAWAGAAMTVLGLGTAALALRLTKRPAPGHVVARSRGAGGTTPSEPARGKATSSC	6.65	gnl|BL_ORD_ID|664|hsp_num:0	703
NODE_18900_length_1105_cov_21.4838_2 # 987 # 1103 # -1 # ID=18900_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.350	NODE_18900_length_1105_cov_21.4838_2 	987	1103	-	Loose	750	25.0238	tetX	40.62	3000205	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	GGTATCTACAACATTTTCAAGTTGCTGCACGTTGAATATGTACATCGTTTCACTTATCGTGATAATCCGGGTATCAACAAAAACGGTATTCGTTTCATGGTATTAATGGTATTCTAG	GIYNIFKLLHVEYVHRFTYRDNPGINKNGIRFMVLMVF	MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADKKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFMYGKEAQEESTQNEIEMFKPDFTFQQLLNV	9.79	gnl|BL_ORD_ID|734|hsp_num:0	776
NODE_21023_length_967_cov_1.86404_3 # 836 # 967 # 1 # ID=21023_3;partial=01;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.606	NODE_21023_length_967_cov_1.86404_3 	836	967	+	Strict	500	22.3274	OXA-29	100.0	3001424	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAAAATATTGGCCCTGGAGTCCTCCGCCACCGCCTGCTCGGTGGCGCTGTGTGAGGATGAGGCTCTGATTGCCCAGTCCTTCCAGAACAATGGCCTGACCCACTCCCGCACCCTCATGCCCATGGCCGTA	MKILALESSATACSVALCEDEALIAQSFQNNGLTHSRTLMPMAV	MKKLSVLLWLTLFYCGTIWAQSTCFLVQENQTVLKHEGKDCNKRFAPESTFKIALSLMGFDSGILKDTLNPEWPYKKEYELYLNVWKYPHNPRTWIRDSCVWYSQVLTQQLGMTRFKNYVDAFHYGNQDISGDKGQNNGLTHSWLSSSLAISPSEQIQFLQKIVNKKLSVNPKAFTMTKDILYIQELAGGWKLYGKTGNGRQLTKDKSQKLSLQHGWFIGWIEKDGRVITFTKHIADSKKHVTFASFRAKNETLNQLFYLINELEK	16.54	gnl|BL_ORD_ID|1872|hsp_num:0	1955
NODE_22038_length_915_cov_0.937209_2 # 688 # 915 # 1 # ID=22038_2;partial=01;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.605	NODE_22038_length_915_cov_0.937209_2 	688	915	+	Strict	400	21.1718	Erm(38)	100.0	3000601	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGGCCGGCCGTTACCAGGGTTTCCTTGTTGGCCAGGGCAATGTCCTTTCCTGCTTCCATGGCGGCAATGGTGGGACGAATTCCAATCATCCCCACCACGGCCGTCACCACCAGGTCTGCCTCCGGCGACACGGCTGCCTCCATCAGTCCCTCCATGCCGCTTGCCACCTTCACATCCATATCAGCTACCGCGGCCCGCAGTTCCTTTGCCTTCTCTTCATCCCAGAG	MAGRYQGFLVGQGNVLSCFHGGNGGTNSNHPHHGRHHQVCLRRHGCLHQSLHAACHLHIHISYRGPQFLCLLFIPE	MSTPHHGRHELGQNFLSDRRVIADIVEIVSRTNGPIIEIGAGDGALTIPLQRLARPLTAVEVDARRARRLAQRTARSAPGPASRPTEVVAADFLRYPLPRSPHVVVGNLPFHLTTAILRRLLHGPGWTTAVLLMQWEVARRRAAVGGATMMTAQWWPWFEFGLARKVSAASFTPRPAVDAGLLTITRRSRPLVDVADRARYQALVHRVFTGRGHGMAQILQRLPTPVPRTWLRANGIAPNSLPRQLSAAQWAALFEQTRLTGAQRVDRPRDVQHGRAHRRRGGEVDRPATHHKQTGPVVGQRQPQRGRDADADPDDQRTAPPVTRHHQGERRDEDQADHQDRPLTGEHLAGEFLWRHASFDSSASTTLVSRKARVNGPTPPGLGDT	19.69	gnl|BL_ORD_ID|1048|hsp_num:0	1097
NODE_22724_length_882_cov_1.12334_2 # 633 # 881 # 1 # ID=22724_2;partial=01;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.458	NODE_22724_length_882_cov_1.12334_2 	633	881	+	Loose	225	24.6386	FosB	38.46	3000172	protein homolog model	n/a	n/a	fosfomycin	antibiotic inactivation	fosfomycin thiol transferase	ATGAATTGTAAGAATTGTTATCAGGAAATTCCTGATGGAAGTAAGTTCTGTCCACATTGCGGTGCGAAGCAGAATGAAGTACAGCCCAATGCAGAACAGGAAAATGCAGTGAAGAATGATCCGGTACAGGCAACGGGGGCAGCAAAGACAACTGAAAATGCAACGGGTTACCAGGATGCAGCAGGTTATCAGAACAACAGCGGCTATCAGGATGCAGCAGGTTATCAGAACAACAGCGGTTATCAGGAT	MNCKNCYQEIPDGSKFCPHCGAKQNEVQPNAEQENAVKNDPVQATGAAKTTENATGYQDAAGYQNNSGYQDAAGYQNNSGYQD	MLRGINHICFSVSNLENSIMFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHIPRNEVHQSYTHIAFSVEQEDFKCLIQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGTLQDRLNYYRDEKPHMTFY	60.14	gnl|BL_ORD_ID|1494|hsp_num:0	1567
NODE_22946_length_873_cov_93.7738_1 # 1 # 807 # 1 # ID=22946_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.343	NODE_22946_length_873_cov_93.7738_1	1	807	+	Strict	400	531.561	ErmF	98.5	3000498	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	TTACTAATGACAAAAAAGAAATTGCCCGTTCGTTTTACGGGTCAGCACTTTACTATTGATAAAGTGCTAATAAAAGATGCAATAAGACAAGCAAATATAAGTAATCAGGATACGGTTTTAGATATTGGGGCAGGCAAGGGGTTTCTTACTGTTCATTTATTAAAAATCGCCAACAATGTTGTTGCTATTGAAAACGACACAGCTTTGGTTGAACATTTACGAAAATTATTTTCTGATGCCCGAAATGTTCAAGTTGTCGGTTGTGATTTTAGGAATTTTGCAGTTCCGAAATTTCCTTTCAAAGTGGTGTCAAATATTCCTTATGGCATTACTTCCGATATTTTCAAAATCCTGATGTTTGAGAGTCTTGGAAATTTTCTGGGAGGTTCCATTGTCCTTCAGTTAGAACCTACACAAAAGTTATTTTCGAGGAAGCTTTACAATCCATATACCGTTTTCTATCATACTTTTTTTGATTTGAAACTTGTCTATGAGGTAGGTCCTGAAAGTTTCTTTCCACCGCCAACTGTCAAATCAGCCCTGTTAAACATTAAAAGAAAACAGTTATTTTTTGATTTTAAGTTTAAAGCCAAATACTTAGCATTTATTTCCTGTCTGTTAGAGAAACCTGATTTATCTGTAAAAACAGCTTTAAAGTCGATTTTCAGGAAAAGTCAGGTCAGGTCAATTTCGGAAAAATTCGGTTTAAACCTTAATGCTCAAATTGTTTGTTTGTCTCCAAGTCAATGGGTAAACTGTTTTTTGGAAATGCTGGAAGTTGTCCCTGAAAAATTTCATCCTTCGTAG	LLMTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVAIENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFESLGNFLGGSIVLQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFFPPPTVKSALLNIKRKQLFFDFKFKAKYLAFISCLLEKPDLSVKTALKSIFRKSQVRSISEKFGLNLNAQIVCLSPSQWVNCFLEMLEVVPEKFHPS	MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVAIENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFESLGNFLGGSIVLQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFLPPPTVKSALLNIKRKHLFFDFKFKAKYLAFISYLLEKPDLSVKTALKSIFRKSQVRSISEKFGLNLNAQIVCLSPSQWLNCFLEMLEVVPEKFHPS	100.75	gnl|BL_ORD_ID|586|hsp_num:0	621
NODE_23073_length_867_cov_1.383_2 # 804 # 866 # 1 # ID=23073_2;partial=01;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.429	NODE_23073_length_867_cov_1.383_2 	804	866	+	Loose	900	20.4014	lmrB	38.1	3002813	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGCAGGAAGAAAAAACGGTCTTGGCAGAGGCTTAGATGCATTTTTTCCAGACAGAACATCT	MAGRKNGLGRGLDAFFPDRTS	METTAKASQQYKVMPIMISLLLAGFIGMFSETALNIALTDLMKELNITAATVQWLTTGYLLVLGILVPVSGLLLQWFTTRQLFTVSLIFSILGTFIAALAPSFSFLLAARIVQALGTGLLLPLMFNTILVIFPPHKRGAAMGTIGLVIMFAPAIGPTFSGLVLEHLNWHWIFWISLPFLVLALVFGIAYMQNVSETTKPKIDVLSIILSTIGFGGIVFGFSNAGEGSGGWSSPTVIVSLIVGVVGLILFSIRQLTMKQPMMNLRAFKYPMFILGVIMVFICMMVILSSMLLLPMYLQGGLVLTAFASGLVLLPGGILNGFMSPVTGRLFDKYGPKWLVIPGFVIVTVVLWFFSNVTTTSTAVLIIILHTCLMIGISMIMMPAQTNGLNQLPREFYPDGTAIMNTLQQMAGAIGTAVAVSIMAAGQHDYMSTVKNPADPAVIPQALTAGVQHAFVFAMIVAIIGLIGAFFMKRVKVDH	4.40	gnl|BL_ORD_ID|558|hsp_num:0	592
NODE_24218_length_820_cov_2.88366_1 # 1 # 819 # -1 # ID=24218_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.360	NODE_24218_length_820_cov_2.88366_1	1	819	-	Strict	500	565.074	aad(6)	100.0	3002628	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(6)	GGGTCACGCGCAAATATTAATATACCTAAAGATGAATTTCAGGATTATGATATTACATATTTTGTAAGTGATATAGAACCGTTTATATCTAATGATGACTGGCTTAATCAATTTGGGAATATAATAATGATGCAAAAGCCGGAGGATATGGAATTATTCCCACCTGAAGAAAAGGGATTTTCCTATCTTATGCTATTTGATGATTACAATAAAATTGATCTTACCTTATTGCCCTTGGAAGAGTTAGATAATTACCTAAAGGGCGATAAATTAATAAAGGTTCTAATTGATAAAGATTGTAGAATTAAAAGGGACATAGTTCCGACTGATATAGATTATCATGTAAGAAAGCCAAGCGCAAGGGAGTATGATGATTGCTGCAATGAATTTTGGAATGTAACACCTTATGTTATTAAAGGATTGTGCCGTAAGGAAATTTTATTTGCTATTGATCATTTTAATCAGATTGTTCGCCATGAGCTGCTGAGAATGATATCATGGAAGGTCGGCATCGAAACAGGCTTTAAATTAAGTGTAGGCAAGAACTATAAGTTTATTGAAAGGTATATATCCGAGGATTTGTGGGAGAAACTTTTGTCCACCTACCGGATGGATTCCTATGAAAACATATGGGAAGCATTATTTCTATGCCATCAATTGTTCAGGGCGGTATCCGGTGAGGTGGCGGAAAGGCTTCATTATGCCTATCCGGAGTATGATAGGAATATAACAAAATATACCAGGGACATGTATAAAAAATACACTGGTAAAACCGGCTGCCTGGATAGCACATATGCCGCTGATATAGAAGAGAGGCGG	GSRANINIPKDEFQDYDITYFVSDIEPFISNDDWLNQFGNIIMMQKPEDMELFPPEEKGFSYLMLFDDYNKIDLTLLPLEELDNYLKGDKLIKVLIDKDCRIKRDIVPTDIDYHVRKPSAREYDDCCNEFWNVTPYVIKGLCRKEILFAIDHFNQIVRHELLRMISWKVGIETGFKLSVGKNYKFIERYISEDLWEKLLSTYRMDSYENIWEALFLCHQLFRAVSGEVAERLHYAYPEYDRNITKYTRDMYKKYTGKTGCLDSTYAADIEERR	EGSRANINIPKDEFQDYDITYFVSDIEPFISNDDWLNQFGNIIMMQKPEDMELFPPEEKGFSYLMLFDDYNKIDLTLLPLEELDNYLKGDKLIKVLIDKDCRIKRDIVPTDIDYHVRKPSAREYDDCCNEFWNVTPYVIKGLCRKEILFAIDHFNQIVRHELLRMISWKVGIETGFKLSVGKNYKFIERYISEDLWEKLLSTYRMDSYENIWEALFLCHQLFRAVSGEVAERLHYAYPEYDRNITKYTRDMYKKYTGKTGCLDSTYAADIEERREQ	98.91	gnl|BL_ORD_ID|1489|hsp_num:0	1562
NODE_24880_length_794_cov_44.1218_1 # 1 # 756 # 1 # ID=24880_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.427	NODE_24880_length_794_cov_44.1218_1 	1	756	+	Strict	1200	531.561	tetO	100.0	3000190	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	TCTTTTTTGGGGAATGTGCAGATGGAAGTCATTTGTGCCATCCTTGAGGAAAAATATCATGTGGAGGCAGAAATAAAAGAGCCTACTGTTATATATATGGAAAGACCGCTTAGAAAAGCAGAATATACCATCCACATAGAAGTCCCGCCAAATCCTTTCTGGGCTTCTGTCGGGTTGTCCATAGAGCCGCTCCCTATTGGAAGCGGAGTGCAGTATGAAAGCAGAGTTTCACTTGGATATTTAAATCAATCGTTCCAAAATGCGGTTATGGAGGGGGTTCTTTATGGCTGCGAGCAGGGGCTGTATGGATGGAAAGTGACAGACTGTAAAATCTGTTTTGAATATGGATTGTATTATAGTCCTGTAAGTACCCCCGCAGACTTTCGGCTGCTTTCCCCTATCGTATTGGAGCAGGCTTTAAAAAAAGCAGGGACAGAACTATTAGAGCCATATCTCCACTTTGAAATTTATGCACCGCAGGAATATCTCTCACGGGCGTATCATGATGCTCCAAGGTATTGTGCAGATATTGTAAGTACTCAGATAAAGAATGACGAGGTCATTCTGAAAGGAGAAATCCCTGCTAGATGTATTCAAGAATACAGGAACGATTTAACTTATTTCACAAATGGGCAGGGAGTCTGCTTGACAGAGTTAAAAGGATACCAGCCAGCTATTGGTAAATTTATTTGCCAACCCCGCCGCCCGAATAGCCGTATAGATAAGGTTCGGCATATGTTCCACAAGTTAGCTTAA	SFLGNVQMEVICAILEEKYHVEAEIKEPTVIYMERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEGVLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYLHFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQGVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA	MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAVTSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMKIPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIMGNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGTRQLIEVIASKFYSSTPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMYVPTNGELYSSDTACSGDIVILPNDVLQLNSILGNEILLPQRKFIENPLPMIQTTIAVKKSEQREILLGALTEISDCDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIYMERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEGVLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYLHFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQGVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA	39.28	gnl|BL_ORD_ID|1931|hsp_num:0	2020
NODE_25473_length_771_cov_1.93156_2 # 710 # 769 # 1 # ID=25473_2;partial=01;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.483	NODE_25473_length_771_cov_1.93156_2 	710	769	+	Loose	550	18.4754	APH(2'')-IIIa	46.67	3002636	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(2'')	ATGAATGTGCCACAACATGTTGCGATCATATTGGATGGAGACGGACGCTGGGCAAAAGCA	MNVPQHVAIILDGDGRWAKA	MKQNKLHYTTMIMTQFPDISIQSVESLGEGFRNYAILVNGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMAVFPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDPDYDYVYLLEDCGELFTRQVMAYRGEVDLDTHIRKVSLFVTFDQVSYLLEGLRARDQDWISEGLELLEEDKANNFGANSA	6.54	gnl|BL_ORD_ID|972|hsp_num:0	1013
NODE_26173_length_745_cov_163.296_1 # 3 # 743 # 1 # ID=26173_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.331	NODE_26173_length_745_cov_163.296_1	3	743	+	Strict	400	493.812	ErmB	99.18	3000375	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	TACATGAACAAAAATATAAAATATTCTCAAAACTTTTTAACGAGTGAAAAAGTACTCAACCAAATAATAAAACAATTGAATTTAAAAGAAACCGATACCGTTTACGAAATTGGAACAGGTAAAGGGCATTTAACGACGAAACTGGCTAAAATAAGTAAACAGGTAACGTCTATTGAATTAGACAGTCATCTATTCAACTTATCGTCAGAAAAATTAAAACTGAATACTCGTGTCACTTTAATTCACCAAGATATTCTACAGTTTCAATTCCCTAACAAACAGAGGTATAAAATTGTTGGGAATATTCCTTACCATTTAAGCACACAAATTATTAAAAAAGTGGTTTTTGAAAGCCGTGCGTCTGACATCTATCTGATTGTTGAAGAAGGATTCTACAAGCGTACCTTGGATATTCACCGAACACTAGGGTTGCTCTTGCACACTCAAGTCTCGATTCAGCAATTGCTTAAGCTGCCAGCGGAATGCTTTCATCCTAAACCAAAAGTAAACAGTGTCTTAATAAAACTTACCCGCCATACCACAGATGTTCCAGATAAATATTGGAAGCTATATACGTACTTTGTTTCAAAATGGGTCAATCGAGAATATCGTCAACTGTTTACTAAAAATCAGTTTCATCAAGCAATGAAACACGCCAAAGTAAACAATTTAAGTACCATTACTTATGAGCAAGTATTGTCTATTTTTAATAGTTATCTATTATTTAACGGGAGGAAATAA	YMNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELDSHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKKVVFESRASDIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTTDVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTITYEQVLSIFNSYLLFNGRK	MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELDSHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGSIPYNLSTQIIKKVVFESRASDIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTTDVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTITYEQVLSIFNSYLLFNGRKLIL	99.19	gnl|BL_ORD_ID|1477|hsp_num:0	1549
NODE_27209_length_709_cov_1.59633_1 # 1 # 72 # 1 # ID=27209_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.542	NODE_27209_length_709_cov_1.59633_1 	1	72	+	Loose	500	19.631	OXA-63	70.0	3001764	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	AAGCCTGTGGACATCAGCGCACTGGAACAGGTGGTAAAGCGCTTCCGCGTTACCCCCCCCGAAAATAAATAG	KPVDISALEQVVKRFRVTPPENK	MSKKNFILIFIFVILISCKNTEKISNETTLIDNIFTNSNAEGTLVIYNLNDDKYIIHNKERAEQRFYPASTFKIYNSLIGLNEKAVKDVDEVFYKLMAKSFLESWAKDSNLRYAIKNSQVPAYKELARRIGIKKMKENIEKLDFGNKSIGDSVDTFWLEGPLEISAMEQVKLLTKLAQNELQYPIEIQKAISDITITRANLHITLHGKTGLADSKNMTTEPIGWFVGWLEENDNIYVFALNIDNINSDDLAKRINIVKESLKALNLLK	8.58	gnl|BL_ORD_ID|739|hsp_num:0	782
NODE_27751_length_692_cov_1.04082_2 # 535 # 690 # 1 # ID=27750_2;partial=01;start_type=ATG;rbs_motif=AAA;rbs_spacer=4bp;gc_cont=0.397	NODE_27751_length_692_cov_1.04082_2 	535	690	+	Loose	700	23.483	vanWI	52.94	3003724	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanW; glycopeptide resistance gene cluster	ATGCCAGAACATGAGCAGAGCGTCTGTTGCCTTAATATGATAGGTTATAAAGTAAGTGCCGGTTACGGGAAACGTAAAAATGGTATTGGCAGCATTTATTGTAAAGCAATTGAGAAACTGGTCGTTTGGAAGCGGGATTGCTATTTTGCCTATAAT	MPEHEQSVCCLNMIGYKVSAGYGKRKNGIGSIYCKAIEKLVVWKRDCYFAYN	MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK	13.94	gnl|BL_ORD_ID|2107|hsp_num:0	2242
NODE_28016_length_685_cov_2.86349_2 # 579 # 683 # -1 # ID=28015_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.590	NODE_28016_length_685_cov_2.86349_2 	579	683	-	Loose	500	23.483	OXA-62	45.45	3001792	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGGATTTTGACGAGGCAATGGCCCGAGGCACCATGTACCGCCCCTTTGAGGCTCACGCCCGGGAGGCTGCCTGCAACCTGTTCAAGACTCAGGAGGGAATGTAA	VDFDEAMARGTMYRPFEAHAREAACNLFKTQEGM	MNTIISRRWRAGLWRRLVGAVVLPATLAATPAAYAADVPKAALGRITERADWGKLFAAEGVKGTIVVLDARTQTYQAYDAARAEKRMSPASTYKIFNSLLALDSGALDNERAIIPWDGKPRRIKNWNAAMDLRTAFRVSCLPCYQVVSHKIGRRYAQAKLNEVGYGNRTIGGAPDAYWVDDSLQISAREQVDFVQRLARGTLPFSARSQDIVRQMSIVEATPDYVLHGKTGWFVDKKPDIGWWVGWIERDGNITSVAINIDMLSEADAPKRARIVKAVLKDLKLI	11.93	gnl|BL_ORD_ID|1345|hsp_num:0	1411
NODE_28843_length_663_cov_3.61678_2 # 579 # 662 # -1 # ID=28842_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.595	NODE_28843_length_663_cov_3.61678_2 	579	662	-	Loose	500	21.9422	sgm	38.89	3000862	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	GCCCGCGGCACCATGTACCGCCCCTTTGAGGCAAAGGCCCGCGAGAAGGCCTGCAATCTGTTCAAGACTGAGGAGGCAAAGTAA	ARGTMYRPFEAKAREKACNLFKTEEAK	MTAPAADDRIDEIERAITKSRRYQTVAPATVRRLARAALVAARGDVPDAVKRTKRGLHEIYGAFLPPSPPNYAALLRHLDSAVDAGDDEAVRAALLRAMSVHISTRERLPHLDEFYRELFRHLPRPNTLRDLACGLNPLAAPWMGLPAETVYIASDIDARLVGFVDEALTRLNVPHRTNVADLLEDRLDEPADVTLLLKTLPCLETQQRGSGWEVIDIVNSPNIVVTFPTKSLGQRSKGMFQNYSQSFESQARERSCRIQRLEIGNELIYVIQK	9.85	gnl|BL_ORD_ID|1979|hsp_num:0	2079
NODE_28920_length_661_cov_19.9884_1 # 64 # 558 # -1 # ID=28919_1;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.325	NODE_28920_length_661_cov_19.9884_1	64	558	-	Perfect	300	332.413	dfrF	100.0	3002867	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGATAGGTTTGATTGTTGCGAGGTCAAAGAATAATGTTATAGGCAAGAATGGTAATATACCATGGAAAATAAAGGGAGAACAAAAGCAATTTAGAGAGTTAACAACGGGTAATGTGGTTATTATGGGGCGAAAGTCTTATGAAGAAATCGGTCATCCGTTGCCTAATAGAATGAATATTGTTGTTTCCACCACAACAGAGTATCAAGGAGATAATTTAGTTTCAGTTAAATCATTAGAAGATGCATTATTATTGGCTAAAGGACGAGATGTATACATATCTGGTGGATATGGACTATTTAAGGAAGCTTTGCAAATAGTAGATAAAATGTATATCACAGAAGTAGATTTAAATATTGAAGATGGAGATACATTCTTTCCAGAATTTGATATCAATGATTTTGAAGTTTTGATAGGGGAAACACTTGGTGAGGAAGTGAAATATACGAGAACATTTTATGTAAGGAAAAATGAATTGAGTAGATTTTGGATTTAG	MIGLIVARSKNNVIGKNGNIPWKIKGEQKQFRELTTGNVVIMGRKSYEEIGHPLPNRMNIVVSTTTEYQGDNLVSVKSLEDALLLAKGRDVYISGGYGLFKEALQIVDKMYITEVDLNIEDGDTFFPEFDINDFEVLIGETLGEEVKYTRTFYVRKNELSRFWI	MIGLIVARSKNNVIGKNGNIPWKIKGEQKQFRELTTGNVVIMGRKSYEEIGHPLPNRMNIVVSTTTEYQGDNLVSVKSLEDALLLAKGRDVYISGGYGLFKEALQIVDKMYITEVDLNIEDGDTFFPEFDINDFEVLIGETLGEEVKYTRTFYVRKNELSRFWI	100.00	gnl|BL_ORD_ID|2|hsp_num:0	5
NODE_29012_length_658_cov_1.06965_2 # 385 # 657 # -1 # ID=29011_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.538	NODE_29012_length_658_cov_1.06965_2 	385	657	-	Loose	400	23.0978	DIM-1	44.83	3000848	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	DIM beta-lactamase	ATCCAACTTCACGATGCTTACATTTCTGTCGTAGAAGCATTAAAGCATGGTGGTGTTGCAAATCGGGCTAAAGTCAACATCAAATGGATCGATTCTGAGACAGTCACCCGTGAAAACGCAGCAGAGCTGTTAGGTGATGTCAGCGGTATCCTGGTTCCAGGCGGTTTCGGAAGCCGAGGTATCGATGGTAAGATCTATGCCATCGAGTATGCNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNCCTTGGTATGCAGCTTTCTATCGTAG	IQLHDAYISVVEALKHGGVANRAKVNIKWIDSETVTRENAAELLGDVSGILVPGGFGSRGIDGKIYAIEYAXXXXXXXXXXXXLVCSFLS	MRTHFTALLLLFSLSSLANDEVPELRIEKVKENIFLHTSYSRVNGFGLVSSNGLVVIDKGNAFIVDTPWSDRDTETLVHWIRKNGYELLGSVSTHWHEDRTAGIKWLNDQSISTYATTSTNHLLKENKKEPAKYTLKGNESTLVDGLIEVFYPGGGHTIDNVVVWLPKSKILFGGCFVRSLDSEGLGYTGEAHIDQWSRSAQNALSRYSEAQIVIPGHGKIGDIALLKHTKSLAETASNKSIQPNANASAD	35.86	gnl|BL_ORD_ID|1702|hsp_num:0	1718
NODE_29585_length_643_cov_1.33163_1 # 1 # 99 # -1 # ID=29582_1;partial=10;start_type=ATG;rbs_motif=AAAA;rbs_spacer=12bp;gc_cont=0.455	NODE_29585_length_643_cov_1.33163_1 	1	99	-	Loose	600	21.9422	ROB-1	35.48	3002995	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	ROB beta-lactamase	ATGACCAAATGGGGAGAGAAACCATACCACTCTCTGGACTATATGCTGAGAGAGCGGTTTGGAGAAAAGGTTTATAAGGTCACGCTAAATGGCGGCATG	MTKWGEKPYHSLDYMLRERFGEKVYKVTLNGGM	MLNKLKIGTLLLLTLTACSPNSVHSVTSNPQPASAPVQQSATQATFQQTLANLEQQYQARIGVYVWDTETGHSLSYRADERFAYASTFKALLAGAVLQSLPEKDLNRTISYSQKDLVSYSPETQKYVGKGMTIAQLCEAAVRFSDNSATNLLLKELGGVEQYQRILRQLGDNVTHTNRLEPDLNQAKPNDIRDTSTPKQMAMNLNAYLLGNTLTESQKTILWNWLDNNATGNPLIRAATPTSWKVYDKSGAGKYGVRNDIAVVRIPNRKPIVMAIMSTQFTEEAKFNNKLVEDAAKQVFHTLQLN	10.82	gnl|BL_ORD_ID|562|hsp_num:0	596
NODE_29978_length_634_cov_2.74439_2 # 549 # 632 # -1 # ID=29970_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.690	NODE_29978_length_634_cov_2.74439_2 	549	632	-	Strict	850	18.4754	opmE	100.0	3003700	protein homolog model	n/a	n/a	macrolide antibiotic; carbapenem; tetracycline antibiotic; acridine dye; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GAAGTCCTGCCCACCAGCGGCGGCGACGAGGCCAAGGCCCTGCTGCGCAGCGGCCTGCATATCGCCCGCCGGAGAAGACCGTAA	EVLPTSGGDEAKALLRSGLHIARRRRP	MKPYLRSSLSALILLGGCAAVGPDYAPPSASAPASFGAMPAGIDGSGVEIEWWRGFDEPALESLIQRALAANLDIALAGARLDEAKALLRENREEFLPRGGPAFDYQARRRGEVETPAGQQRDIETYRGALDASWEIDLFGRVRRSVEAAEAQAGSREALLRNVQASVAATVAMSWFQLQGIEAELAVVHDIAGNQRDSLEMVERLVSAGSAHEFDRLRAEALLHNVEAAVPDLERRRAATRNALAVLLAEAPQAFSPPVARASGERLTLRTLGVGDPAGLLARRADIAAAERNLAAATARIGVETAGLYPQVEVRGSIGLVAGNLDALDESGTSFNVLNPVIRWALLDRGRVWARIAASEARAQEALILYDRTVLRALQETDDAFNGYGAAADRLRLRLLEATANREAARLARERFVQGDGEYLDVLEAERSDYLSRRALSIARTEQRLAVVGIYKALGGGWEACAGARRCGVATDDTSPGVARQRDSRS	5.50	gnl|BL_ORD_ID|2089|hsp_num:0	2213
NODE_31042_length_610_cov_1.05225_1 # 64 # 609 # -1 # ID=31025_1;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.330	NODE_31042_length_610_cov_1.05225_1 	64	609	-	Loose	700	23.483	Escherichia coli ampC beta-lactamase	25.0	3004290	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	ampC-type beta-lactamase	AATGTAGAAGAAATTGTAGTTGGATTTGATGGAATTACAATAATAGCTAATAAGACAAATCCAATAAAAGATATTGATGATAAAACTCTAGGAAAAGTATTTAGAGGAGAAATTACTAACTGGAAGGAATTAGGTGGAGATGATGCAGAAATAGTTGTTTTATCAAGAGATTCTTCATCAGGGACACATGAATTCTTTAAGGAGCATATAATCAGAGAAGGAAACTCTAAAGGAACTCAAGAGTATGGGGCTAAAACTCTATATATGCCTTCTAATGAAGCGATAAAACAGGAAATAAAAGCTAATAAATATGCAATAGGTTACATAGGTATGGGATATATGGATTCATCAGTAGAAGCTGTAACAGTAGATGGAGTAGCAGCTACTCCAGAAAATGTATTAAATAAAACATATCCAATAGCTAGAGAAGTTTTCTGGTATGCAGACAGTGCTAGAGAAGGAGTTGTTAAGGAGCTAGTTGATTATGCAGTATCTCCAAAGGGACAAGAAATAATCAAAAATGAAGGATTTGTACCTGTAAAATAG	NVEEIVVGFDGITIIANKTNPIKDIDDKTLGKVFRGEITNWKELGGDDAEIVVLSRDSSSGTHEFFKEHIIREGNSKGTQEYGAKTLYMPSNEAIKQEIKANKYAIGYIGMGYMDSSVEAVTVDGVAATPENVLNKTYPIAREVFWYADSAREGVVKELVDYAVSPKGQEIIKNEGFVPVK	MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSIINGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVDAAWQILNALQ	48.01	gnl|BL_ORD_ID|2342|hsp_num:0	2843
NODE_34495_length_553_cov_1.33333_1 # 2 # 514 # 1 # ID=34332_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.343	NODE_34495_length_553_cov_1.33333_1 	2	514	+	Loose	1320	77.0258	lmrD	64.71	3002882	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	AGAACCAGCTTTGTGATCGCACACAGACTTTCTACCATCAAGGATGCAGACCTGATCCTGGTTATGAAAGACGGTGACATTATCGAGCAGGGAAATCATGAAGAGCTTCTGTCTAAGAAAGGCTTCTATGCAGACCTGTATAACAGTCAGTTTGAGAATAAGGCAACTGCCTGAAATAGAAAATTACAGTATGGAAATCATGATATAAATCATGGTGTAAATCTATGGCAATTTCTGAAAAAATGAAATTACTGTAAGAAAGAAATGTATTATAAATCCCTCAGGGTATTTGTGAAAGAGAATATATCCGGCAGATATAGGATCGCACAGATACTGGATGAGGGATTTTTATTATTGTTTACTGCAGCTTCTTATGGATGCATAGAAACAGATGAATCGAGATATACCGTGCAAATTTACGTCTTTTCTGTAAGAGGGGAATATGTTATAATTAAAAACCAATCTACGAAAATTGATATATTTTATCATCATAATAATAAGAGAAAATGATAA	RTSFVIAHRLSTIKDADLILVMKDGDIIEQGNHEELLSKKGFYADLYNSQFENKATA*NRKLQYGNHDINHGVNLWQFLKK*NYCKKEMYYKSLRVFVKENISGRYRIAQILDEGFLLLFTAASYGCIETDESRYTVQIYVFSVRGEYVIIKNQSTKIDIFYHHNNKRK	ENTKSTRKMSDTTRAIRFFYLYLKRYKLQFAVIMIFIILATWLQVVSPSLLGDAITNLTKYVTDFFTHQHAGQSQDALQQIAQQLSQQMHQTVDWHNVPEVVKSLPQAAQDQITANLPKGTTLETLKTVATSHAASTSTFMKGMWQLLAVYVATGVSMLIYTLLFSRIVAHSTNRMRKGLFGKLERLTISYFDRHQDGDILARFTSDLDNIQNTLNQALVSVISNAAVFVGVIIQIFNKDVTFAWLTVAASPVAILSAVIIIRQSKKATDKQQEEVSQLNAYMDEKISGQKAIIVEGLQEDSINGFLEHNENVKKRTFAAQAWSGMIFPLMNGFQLLSIAIVIFGGTAYVLNDDSMSIATGLGLLVAFVQYVQSYYNPIMQISSNFGQLQLAITGATRLNVMFDEPEEVRPENGKKFDTIKDGIQIENLDFEYLPGKPVLKKVNIDVKKGQMVALVGPTGSGKTTVMNLMNRFYDVNGGAIKFDGTDIREFDLDSLRSNVGIVLQESVLFDGTIADNIKFGKPNATQEEIETVAKTTHIHDFIDSLPDKYETHVSDDESVFSVGQKQQISIARTILTNPELLILDEATSNVDTVTEQQIQWAMEAAIAGRTSFVIAHRLKTILNADKIVVLKDGEVIEEGNHHELVAQGGFYSELYHNQFVF	25.53	gnl|BL_ORD_ID|1550|hsp_num:0	1624
NODE_36181_length_530_cov_1.30737_1 # 1 # 528 # 1 # ID=35831_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.606	NODE_36181_length_530_cov_1.30737_1 	1	528	+	Strict	2200	374.4	Bifidobacterium ileS conferring resistance to mupirocin	98.29	3003730	protein homolog model	n/a	n/a	mupirocin	antibiotic target alteration	antibiotic resistant isoleucyl-tRNA synthetase (ileS)	CGCCGCGCGATCCTCTTCCAGGAGAAAAGCTACGTGCACTCCTACCCGCACTGCTGGCGTTGCGCCACCCCGCTGATCTACAAGCCGGTCTCCTCCTGGTTCGTGTCCGTGACCAAGATCAAGCCGCGTCTATTGGAATTGAACCAGCAGATCAACTGGATCCCGGGCAATGTCAAGGACGGTCAGTTCGGCAAGTGGCTCGCCAACGCGCGCGACTGGTCCATCTCCCGCAACCGCTTCTGGGGTTCCCCGATCCCGGTGTGGGTGAGCGACGATCCGAAGTACCCGCGTGTGGACGTCTACGGTTCTCTCGAAGAGCTCAAGGCCGACTTCGGTGACTACCCGCGCGACAAGGACGGCAACATCAACATGCACCGTCCGTGGATCGACAACCTGGTCCGCGTCAACCCGGACGACCCGACCGGCAAGTCGCACATGCACCGTATTTCCGATGTACTCGACTGCTGGTTCGAGTCCGGTTCCATGTCGTTCGCGCAGTTCCACTACCCGTTCGAGAACAAGGAGAAG	RRAILFQEKSYVHSYPHCWRCATPLIYKPVSSWFVSVTKIKPRLLELNQQINWIPGNVKDGQFGKWLANARDWSISRNRFWGSPIPVWVSDDPKYPRVDVYGSLEELKADFGDYPRDKDGNINMHRPWIDNLVRVNPDDPTGKSHMHRISDVLDCWFESGSMSFAQFHYPFENKEK	MSETTNSHVYPKANEGGETASVAPNPSFPNMEETVLKYWDKDDTFNKSVERNPSGDHSQNEFVFFDGPPFANGLPHYGHLLTGYAKDVIPRYQTMKGRKVNRVFGWDTHGLPAELEAQKELGIDSVDQIEKMGIDKFNDACRASVLKYTHEWQDYVHRQARWVDFEHGYKTLNIPYMESVMWAFKQLYEKGLAYQGYRVLPYCPKDQTPLSAHELRMDADVYQDRQDTTVSVAVKLRDEEDAYAVFWTTTPWTVPTNFAIVVGADIDYVEVRPTQGKYAGKKFYFGKPLLSKYEKELGEDYEVVRELKGSEMAGWRYWPVFPYFAGDKAESEGNVPGPEGYQIFTADYVDTVEGTGLVHQAPYGEDDMNTLNAHGIKSTDVLDAGCRFTAQCPDYEGMYVFDANKPILRNLRNGDGPLAEIPAEHRAILFQEKSYVHSYPHCWRCATPLIYKPVSSWFVSVTKIKPRLLELNQQINWIPENVKDGQFGKWLANARDWSISRNRFWGSPIPVWVSDDPKYPRVDVYGSLEELKADFGDYPRDKDGNVNMHRPWIDNLTRVNPDDPTGKSHMHRISDVLDCWFESGSMSFAQFHYPFENKEKFEQHFPADYIVEYIGQTRGWFYLLHVMATALFDRPAFKNVICHGIVLGSDGQKMSKHLRNYPDVNGVFDKYGSDAMRWFLMSSPILRGGNLIVTAEGIRDTVRQVMLPVWSSYYFFTLYANAANGGAGFDARQLRADEVAGLPEMDRYLLARTRRLVERVEKSLDEFAISDACDAASDFIDVLTNWYIRNTRDRFWKEDVNAFNTLYTVLEVFMRVLAPLAPMESESVWRGLTGGESVHLADWPYVADEKTGEATELGRVLVDDPALVDAMEKVREIVSGALSLRKAAQIRVRQPLAKLTVVVEDVDAVKAYDEILKSELNIKDIEFCTMEDAGSQGLKIVHELKVNARAAGPRLGKQVQFAIKASKTGAWHVDAATGAPVVETPNGEVALEAGEYELINRVEEENAAEADASVSAALPTGGFVILDTVLTADLEAEGYARDVIRAVQDARKAADLDIADRIALVLTVPSANVADVERFRDLIAHETLATSFAVKEGAELGVEVAKA	15.90	gnl|BL_ORD_ID|2128|hsp_num:0	2278
NODE_36347_length_528_cov_1.05708_1 # 2 # 211 # -1 # ID=35978_1;partial=10;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.471	NODE_36347_length_528_cov_1.05708_1 	2	211	-	Loose	650	23.483	vanE	45.0	3002907	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; van ligase	GTGCCGCCAGGAGCCAATGGAGTCCTGTTTTTGCCATATTTGACTGGTGGCTTTGGAGAAATTTCTGCTGCCAGCGGTTGCTTTCTGAATATGACTATGGATACAGATCAGGCTGTTTTGTGGCGTGCGGTCTTGGAAGCCATTGCTTATGATTATATCGGTGTCACAGATGTATATCGTTCCGCTGGTGTGGATCTGAAGCACATCGTT	VPPGANGVLFLPYLTGGFGEISAASGCFLNMTMDTDQAVLWRAVLEAIAYDYIGVTDVYRSAGVDLKHIV	MKTVAIIFGGVSSEYEVSLKSAVAIIKNMESIDYNVMKIGITEEGHWYLFEGTTDKIKKDRWFLDESCEEIVVDFAKKSFVLKNSKKIIKPDILFPVLHGGYGENGAMQGVFELLDIPYVGCGIGAAAISMNKIMLHQFAEAIGVKSTPSMIIEKGQDLQKVDAFAKIHGFPLYIKPNEAGSSKGISKVERKSDLYKAIDEASKYDSRILIQKEVKGVEIGCGILGNEQLVVGECDQISLVDGFFDYEEKYNLVTAEILLPAKLSIDKKEDIQMKAKKLYRLLGCKGLARIDFFLTDDGEILLNEINTMPGFTEHSRFPMMMNEIGMDYKEIIENLLVLAVENHEKKLSTID	19.89	gnl|BL_ORD_ID|1539|hsp_num:0	1617
NODE_36518_length_526_cov_1.2845_2 # 434 # 526 # 1 # ID=36124_2;partial=01;start_type=ATG;rbs_motif=TACAA;rbs_spacer=13bp;gc_cont=0.430	NODE_36518_length_526_cov_1.2845_2 	434	526	+	Loose	1500	20.0162	rphB	54.55	3003992	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	ATGGACAATGGGAGGTGGAAGAGTGTGATTAAAATTGTATTTTTTGCACCATATCCGGACATTCTTCCTGTCATTGAGCAGGTGTTCCGGGAA	MDNGRWKSVIKIVFFAPYPDILPVIEQVFRE	MRSLVLDFQEMDKKQLGLVGGKGLHLGELSKIEGIRVPEGFCVTTIGYQRAIEQNETYQAMLNRLTMLSAEDRDQMVEISRKIRQTIMEVEIPSDVVTAVTRYLSRFGEEQAYAVRSSATAEDLPHASFAGQQDTYLNIIGVDAILQHISKCWASLFTDRAVIYRMQNGFDHRQVYLSVVVQRMVFPEASGILFTADPMTSNRKLLSIDAGFGLGEALVSGLVSADGYKVREGEIIEKRIAAKTLAIYGRKEGGTETKQIDPDQQKSQTLTDEQILQLARIGRQIEAHFGQPQDIEWCLAQDTFYIVQSRPITTLYPIPEANDQENHVYVSVGHQQMMTDPMKPLGLSFFLLTTPAPMRTAGGRLFVDTTAMLASPVSRENVLNTLGQSDPLIKDALMTILERGDFIKSLPIAENEQTPGKNNISSAGYQTPIDHDPTIVSDLMERTQSSIEVLKQNIQTKSGSDLFDFILEDIQELKKNLFDPQSSAVIMAAMNASTWINEKMNEWLGEKNAADTLSQSVPGNVTSEMGLALLDVADVIRPYPEIIDYLEQAKDDHFLDKLLTFDGGQQAQDAILDFLDKYGMRCAGEIDLTRTRWSEKPIALVPLILGNIKNFEPNASHRKFEQGRQEALKKEQELLDRLKQLPDGEGKAQETKRMIDLIRNFMGYREYPKYGMVNRYFIYKQALLKEAERLVQAGVIHHKEDIYYLTFEELDEVVRTNKLDNPGSMVEQQAKLAIRQMISKRKEEYNVFEKLTPPRVITSDGEIIAGEYKRENIPAEAIVGLPVSSGTVEGRARVILNMKDADLEEGDILVTAFTDPSWTPLFVSIKGLVTEVGGLMTHGAVIAREYGLPAVVGVENATKRIKDGQRIRVHGSEGYIEILS	3.51	gnl|BL_ORD_ID|2242|hsp_num:0	2528
